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9ABSTRACT
The aim of the study was to evaluate a range of potential risk factors in the etiology of 
varicose veins by a longitudinal follow-up study in a general middle-aged population. 
Studied factors were parity, use of oral contraceptives and hormone replacement 
therapy, lifestyle factors and self-reported family history of varicose veins. The 
purpose was also to evaluate misclassification in self-reported family history of 
varicose veins. 
The five-year follow-up data was obtained through postal questionnaires from 
three cohorts of residents of the city of Tampere in Finland. The number of original 
target population of 40-, 50- and 60-year-olds was 6,874. The response rate was 81% 
(5,568) at entry. An almost identical questionnaire was sent five years later to those 
who had responded to the first questionnaire and the response rate was 88% (4,903). 
The questionnaire included questions related to medical conditions, lifestyle, varicose 
veins and family history of varicose veins. A sub-sample of subjects underwent a 
physical examination but family members were not clinically examined. Incidence of 
varicose veins was studied as an indicator of risk in those free of varicose veins at 
entry. 
It was found that new varicose veins appeared more often in women with three 
or more births than in nulliparous women, incidence odds ratio, IOR 2.0 (95% 
confidence interval, CI: 1.0–3.9). Subjects who consumed alcohol weekly had a 
higher incidence of varicose veins compared to non-users, IOR 1.5 (95% CI: 1.05–
2.3). The result was statistically significant only in women. Compared to non-smokers, 
subjects who had ever smoked for over a year, and of these heavier smokers (????
cigarettes a day), had higher risk of varicose veins, IORs 1.3 (95% CI: 0.9–1.8) and 
1.8 (95% CI: 1.1–2.8) respectively. Daily use of meat seemed to decrease the risk of 
varicose veins compared to infrequent use (0–2 meals a week) of meat, particularly in 
women. Dietary fiber intake, use of contraceptive pills or hormone replacement 
therapy did not have an effect on the incidence of varicose veins.
In those with a positive family history of varicose veins the risk of varicose 
veins was increased compared to those with negative family history, IOR 1.6 (95% CI: 
1.1–2.3). When genders were studied separately, the higher risk was statistically 
significant only in women, IOR 1.8 (95% CI: 1.1–2.8), but not in men, IOR 1.4 (95% 
CI: 0.7–2.6). The estimates of the risk were much lower than our prevalence results 
(OR 6.6 in men and OR 4.9 in women, respectively) and also those usually reported in 
the literature based on cross-sectional studies with prevalence estimates.
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Subject’s own varicose vein status or change in it was associated with self-
reported family history of varicose veins. For example, if a person who at entry 
reported negative family history developed varicose veins during follow-up, the risk 
of reporting a family member with varicose veins after the follow-up was sixfold, OR 
6.0 (95% CI: 2.0–47.8). If another person reported varicose veins at entry and at the 
end of the follow-up, the risk of reporting a new family member with varicose veins 
was less than 1 (OR 0.8 (95% CI: 0.6–0.9)). 
In conclusion, in women, multiparity, alcohol consumption and positive family 
history of varicose veins increase the risk of varicose veins, whereas meals containing 
meat may reduce the risk. Smoking is likely a risk factor of varicose veins in both 
genders. The strong effect of family history on the risk of varicose veins in the 
literature is affected by differential misclassification bias. 
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TIIVISTELMÄ
Tutkimuksen tavoitteena oli arvioida seurantatutkimuksella joukkoa suonikohjujen 
mahdollisia riskitekijöitä yleisessä keski-ikäisessä väestössä. Tutkittuja tekijöitä olivat 
synnyttäneisyys, ehkäisypillereiden käyttö, hormonikorvaushoito, elämäntapatekijät ja 
itse raportoitu suonikohjujen sukuhistoria. Tarkoituksena oli arvioida myös eriävästä 
virheluokittelusta johtuvaa harhaa sukulaisten suonikohjujen itseraportoinnissa.
Viisivuotinen seuranta-aineisto kerättiin postitetuilla kyselylomakkeilla kol-
melta tamperelaiselta ikäkohortilta. Kohdeväestönä olivat 40-, 50- ja 60-vuotiaat, 
yhteensä 6874 henkilöä. Tutkimuksen alussa vastausprosentti oli 81 % (5568 
henkilöä). Vastanneille lähetettiin lähes samanlainen kyselylomake viisi vuotta myö-
hemmin. Vastausprosentti oli toisessa kyselyssä 88 % (4903 henkilöä). Kyselylomake 
sisälsi kysymyksiä terveydentilasta, elämäntavoista sekä omista ja lähisuvun suoni-
kohjuista. Osa tutkimukseen vastanneista henkilöistä tutkittiin kliinisesti, mutta 
heidän lähisukulaisiaan ei. Riskin osoittamiseen käytettiin uusien suonikohjujen 
ilmaantuvuutta henkilöillä, joilla ei ollut suonikohjuja tutkimuksen alussa.
Uusia suonikohjuja ilmaantui enemmän ainakin kolme lasta synnyttäneille 
naisille kuin synnyttämättömille, ilmaantuvuuden vetosuhde, IOR 2,0 (95 %:n luotta-
musväli 1,0–3,9). Alkoholia viikoittain käyttävillä suonikohjujen ilmaantuvuus oli 
suurentunut verrattuna henkilöihin, jotka eivät käyttäneet alkoholia viikoittain, IOR 
1,5 (1,05–2,3). Tulos oli tilastollisesti merkitsevä vain naisilla. Tupakoimattomiin 
henkilöihin verrattuna henkilöillä, jotka olivat tupakoineet yli vuoden ajan, sekä heistä 
niillä, jotka olivat tupakoineet runsaasti (?????????????????????????oli suurentunut riski 
saada suonikohjut, ensiksi mainituilla IOR 1,3 (0,9–1,8) ja jälkimmäisillä 1,8 (1,1–
2,8). Päivittäinen lihan syöminen näytti vähentävän suonikohjuriskiä varsinkin naisilla,
kun sitä verrattiin vähäiseen (0–2 annosta viikossa) lihan syömiseen. Päivittäisellä 
kuidun saannilla, ehkäisypillereiden käytöllä tai hormonikorvaushoidolla ei todettu 
vaikutusta suonikohjujen ilmaantuvuuteen.
Henkilöillä, joilla suonikohjujen sukuhistoria oli positiivinen, suonikohjuriski 
oli lisääntynyt verrattuna henkilöihin, joilla suonikohjujen sukuhistoria oli nega-
tiivinen, IOR 1,6 (1,1–2,3). Kun miehet ja naiset analysoitiin erikseen, riski oli 
merkitsevästi lisääntynyt naisilla, IOR 1,8 (1,1–2,8), mutta ei miehillä, IOR 1,4 (0,7–
2,6). Ilmaantuvuuden riskiarviot olivat selvästi matalampia kuin tutkimuksemme 
vastaavat vallitsevuustulokset (OR 6,6 miehillä ja OR 4,9 naisilla) sekä kirjalli-
suudessa yleensäkin esitetyt arviot poikkileikkaustutkimusten perusteella. 
Henkilön oma suonikohjustatus tai muutos statuksessa oli yhteydessä siihen, 
miten henkilö raportoi lähisukulaistensa suonikohjuista. Esimerkiksi, jos henkilö 
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ilmoitti tutkimuksen alussa ettei hänen suvussaan ole suonikohjuja, mutta hänelle 
itselleen kuitenkin ilmaantui suonikohjut seurannan aikana, riski suonikohjuisen 
sukulaisen  raportointiin seurannan lopussa kasvoi kuusinkertaiseksi (OR 6,0 (2,0–
47,8)). Jos taas henkilö ilmoitti omaavansa suonikohjut sekä seurannan alussa että 
lopussa, riski suonikohjuisen sukulaisen raportointiin seurannan lopussa oli alle yksi 
(OR 0,8 (0,6–0,9)). 
Johtopäätöksenä voidaan todeta, että naisilla monisynnyttäneisyys, alkoholin 
käyttö ja positiivinen sukuhistoria lisäävät suonikohjuriskiä, kun taas liharuoan käyttö 
saattaa vähentää sitä. Tupakointi on suonikohjujen todennäköinen riskitekijä 
molemmilla sukupuolilla. Kirjallisuudessa esitettyyn voimakkaaseen suonikohjujen 
sukuriskiin liittyy eriävä virheluokitteluharha.
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1.  INTRODUCTION
Primary varicose veins are a typical manifestation of chronic venous insufficiency. 
The etiology of varicose veins is still incompletely understood despite the fact that it 
is a very common disease affecting all ages from teenagers to elderly people. The 
prevalence of varicose veins varies substantially in different parts of the world, being 
highest in the western world; mostly from 10% to 30% in men and from 25% to 55% 
in women in population-based studies (Callam 1994, Beebe-Dimmer et al. 2005, 
Robertson et al. 2008). In population in middle to late adulthood (40–69 years) the 
incidence of varicose veins ranged from 9 to 19 per 1,000 person-years in men and 
from 19 to 26 per 1,000 person-years in women in follow-up studies from Finland and 
the USA (Brand et al. 1988, Mäkivaara et al. 2004).
The prevalence of varicose veins increases with age (Cesarone et al. 2002, 
Crique et al. 2003, Kroeger et al. 2004). Hence every way to prevent the disease in 
this aging world population is worthwhile. Other reported risk factors are female 
gender (Brand et al. 1988, Sisto et al. 1995, Crique et al. 2003, Carpentier et al. 2004), 
parity (Sisto et al. 1995, Criqui et al. 2007), positive family history of varicose veins 
(Cornu-Thenard et al. 1994, Scott et al. 1995, Lee et al. 2003) and obesity in women
(Brand et al. 1988, Lee et al. 2003). There are also many hypothetical postulated risk 
factors such as diet and other lifestyle factors, occupation involving prolonged sitting 
or standing, and hormone medications, but the existing data is inconsistent for further 
conclusions. At the moment, it is assumed that the etiology of varicose veins is 
multifactorial, but the more specific role of both environmental and genetic factors in 
the development of varicose veins is not known (Ng et al. 2005, White and Ryjewski 
2005, Raffetto and Khalil 2008). An understanding of the basis of varicose veins 
formation will provide possible tools for prevention or highlight new tools for 
treatment.
The knowledge of the risk indicators of varicose veins is mainly based on cross-
sectional surveys conducted in a selected population (e.g. hospital or clinic patients or 
occupational groups of only one sex). The temporal relationship between the potential 
risk factor (cause) and the outcome (effect) is very important in estimating causality. 
In cross-sectional studies, the estimation of cause and effect is simultaneous and it is 
often unclear whether the hypothetical cause preceded the effect in time or the 
opposite. Follow-up studies do not have these problems because the incident cases of 
the disease are detected in subjects originally free of it and the data on the risk factors 
is collected at entry of the follow-up.
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There are only a few follow-up studies on the causes of varicose veins. The 
Tampere Varicose Vein Study is one of the first population-based follow-up studies to 
examine varicose veins and their occurrence, risk factors and associations with other 
diseases. As a part of the study, the purpose of this thesis was to evaluate if female 
hormones, specific lifestyle factors and a positive family history of varicose veins are 
risk factors for varicose veins in a middle-aged population.
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2.  REVIEW OF THE LITERATURE
2.1  Definition and classification of varicose veins
Varicose veins are dilated subcutaneous veins three millimeters in diameter or larger, 
measured in an upright position (Eklöf et al. 2004). They are usually bilateral 
affecting both legs (75-76%) (Abramson et al. 1981, Maffei et al. 1986, Hirai et al. 
1990, Komsuoglu et al. 1994) and when unilateral they are detected with the same 
frequency on each leg (Maffei et al. 1986, Hirai et al. 1990, Komsuoglu et al. 1994). 
There was lack of a uniform classification system for chronic venous disorders 
until the 1980s when the first proposed reporting standards for publications dealing 
with venous disease were published (Anonymous 1988). Based on that report, the 
American Venous Forum developed a more detailed descriptive classification system, 
CEAP, for chronic venous disorders in 1994 and this was published in 25 journals and 
books (Eklöf et al. 2004). It was based on clinical manifestations (C), etiological 
factors (E), anatomic distribution of disease (A), and underlying pathophysiological 
findings (P) (Table 1) (Porter and Moneta 1995). In 2004 a revised version of the 
basic CEAP classification (Table1) and advanced CEAP classification was published 
(Eklöf et al. 2004).
Table 1. The basic CEAP classification system.
Clinical signs* Class 0 No visible or palpable signs of venous disease
Class 1 Teleangiectasies or reticular veins
Class 2 Varicose veins (??????????????????
Class 3 Edema
Class 4a
Class 4b
Pigmentation or eczema
Lipodermatosclerosis or atrophien blanche
Class 5 Healed venous ulcer
Class 6 Active venous ulcer
Etiologic factors Congenital, primary, secondary or no venous cause identified
Anatomic distribution Superficial, perforator, deep veins or no venous location 
identified
Pathophysiologic 
findings
Reflux or obstruction, alone or in combination or no venous 
pathophysiology identifiable
*Class supplemented by (S) for symptomatic or (A) for asymptomatic presentation
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Before the CEAP consensus statement, the definition of varicose veins in 
different studies was diverse, making it difficult to compare the results of 
epidemiologic studies. One of the most used definitions has been according to Arnoldi 
(1957) “any dilated, elongated, or tortuous veins, irrespective of size” and the other 
from the Basle study, where varicosities were classified into three types (spiderwebs, 
reticular varices or trunk varices) and each of these into three grades of severity (da 
Silva et al. 1974).
2.2  Occurrence of varicose veins
2.2.1  Geographical distribution
The occurrence of varicose veins has been studied in general populations in Europe 
and the USA, but many prevalence studies are from other defined populations. There 
are only two other longitudinal follow-up studies on the incidence of varicose veins in 
adult population: the Framingham Study from the USA and the San Valentino 
Screening Project from Italy (Brand et al. 1988, Cesarone et al. 2002). (Table 2)
According to review articles, the prevalence of varicose veins ranges from 2% 
to 57% in men and from <1% to 73% in women (Beaglehole 1986, Callam 1994, 
Evans et al. 1994, Beebe-Dimmer et al. 2005, Robertson et al. 2008) and the incidence 
estimate is based on the Framingham Study with a two-year incidence rate of 
39.4/1,000 person-years for men and 51.9/1,000 for women (Callam 1994, Robertson 
et al. 2008). 
Europe and North America. In Finland, the prevalence of varicose veins 
reported earlier from the Tampere Varicose Vein Study population was 18% in men 
and 42% in women (Laurikka 1992, Laurikka et al. 1993). The incidence from the 
five-year follow-up of the same study was 8.5/1,000 person-years in men and 
19.2/1,000 person-years in women (Mäkivaara et al. 2004, Mäkivaara 2008). Another 
population study from Finland, the Mini-Finland Health Survey, reported the 
prevalence of varicose veins diagnosed by a physician to be 7% in men and 25% in 
women aged 30 years and over (Sisto et al. 1995).
A study of general population at four locations in France (n=8,000) found a 
prevalence of varicose veins 30% in men and 51% in women (Carpentier et al. 2004). 
In Italy, in a follow-up study of a total population with 30,000 subjects the total 
prevalence of varicose veins was 7% (Cesarone et al. 2002). In the same study the 
incidence (new cases per year) of varicose veins was 0.22%. In Poland, 28% of the 
men and 35% of the women had varicose veins in a study on 40,095 participants aged 
16–97 (Jawien et al. 2003). 
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In Switzerland, two studies were reported among employees (Guberan et al. 
1973, da Silva et al. 1974). In the Basle Study of 4,422 chemical industry employees 
varicose veins of all types and grades were observed in 57% of the men and 68% of 
the women and severe forms of varicose veins in 4% of the study subjects (da Silva et 
al. 1974).  Of 610 women working in department stores 29% suffered from varicose 
veins or reticular veins, but the prevalence varied significantly depending on the 
country of origin: After standardizing for age, the prevalence of varicose veins was 
significantly lower (20%) among the 154 women from Italy and Spain than among 
others (from Switzerland, France and other Central Europe) (Guberan et al. 1973). 
The prevalence of varicose veins was studied in elderly persons over 60 years 
of age in Turkey, where the prevalence was 35% in men and 38% in women 
(Komsuoglu et al. 1994). In the Edinburgh Vein Study (n=1,566), the age-adjusted 
prevalence of trunk varices was 40% in men and 32% in women aged 18–64 years 
(Evans et al. 1999). In another study in the United Kingdom the prevalence of 
varicose veins was lower for men (17%), but the rate for women (32%) was the same 
as in the Edinburgh Vein Study (Franks et al. 1992). 
In the Framingham Study, during 16 years of follow-up the incidence rate per 
1,000 person-years was 19.7 in men and 25.9 in women aged 40–89 years in a general 
population of 3,822 subjects (Brand et al. 1988). In San Diego, California a cross-
sectional study of a multiethnic sample of 2,211 people aged 40–79 years, current and 
retired employees of the University of California and the spouse of a randomly 
selected participant, reported 15% of the men and 28% of the women to have varicose 
veins (Criqui et al. 2003). In the Tecumseh Community Health Study, Michigan, the 
prevalence of any varicose veins in subjects aged 10–70+ (n=6,389) was 13% in 
males and 26% in females. In the same study the respective prevalence of varicose 
veins 2+ or greater i.e. “significant” varices was 7% and 17% (Coon et al. 1973).
Asia. In general population of Israel, the prevalence of varicose veins was 10% 
among men and 29% among women aged 15 and over (Abramson et al. 1981). The 
other studies from Asia are on populations subject to different selections. The highest 
prevalence of all kinds of varicosities (45%) was reported in females in a Japanese 
study (Hirai et al. 1990) and the lowest prevalence of varicose veins (1%) was 
reported in female government employees with a mean age of 27 years (Colin 1972). 
There are also data from five investigators who examined adult hospital patients in 
India and anecdotally reported prevalence of varicose veins ranging between <1 and 
2% in men and between 0 and 1 percent in women (Burkitt et al. 1975).
Table 2. Studies (N>200) on the occurrence of varicose veins by geographical distribution.  
 
Region Country N Age at 
entry 
(years) 
Population Design Result Reference 
Finland 6874 
8000 
4903 
40–60 
≥30 
40–60 
General population 
General population 
General population 
Cross-sectional 
Cross-sectional 
Follow-up, 5 years 
P=18% in men and 42% in women 
P=7% in men and 25% in women 
I=8.5/1000 in men and 19.2/1000 in women 
Laurikka et al. 1993 
Sisto et al. 1995 
Mäkivaara et al. 2004 
France 7432 
8000 
42–53 
≥18 
Male employees 
General population 
Cross-sectional 
Cross-sectional 
P=10% in men 
P=30% in men and 51% in women 
Ducimetiere et al.1981 
Carpentier et al. 2004 
Italy 1319 
30000 
>65 
Any 
General population 
General population  
Cross-sectional 
Follow-up, 6 years 
P=17% in men and 35% in women 
I=2.2/1000 
Canonico et al. 1998 
Cesarone et al. 2002 
Poland 40095 16–97 Outpatient clinic patients Cross-sectional P=28% in men and 35% in women Jawien et al. 2003 
Switzerland 4422 
610 
20–70 
≥15 
Industrial employees 
Female store employees 
Cross-sectional 
Cross-sectional 
P=57% in men and 68% in women 
P=29% in women 
da Silva et al. 1974 
Guberan et al. 1973 
Turkey 856 ≥60 General population Cross-sectional P=35% in men and 38% in women Komsuoglu et al. 1994 
The UK 504 
2103 
1566 
15–74 
35–70 
18–64 
Female cotton workers 
GP-patients 
General population 
Cross-sectional 
Cross-sectional 
Cross-sectional 
P=32% in women 
P=17% in men and 32% in women 
P=40% in men and 32% in women 
Mekky et al. 1969 
Franks et al. 1992 
Evans et al. 1999 
Europe 
and 
North 
America 
USA 6389 
3822 
2211 
≥10 
40–89 
40–79 
General population 
General population 
University employees 
Cross-sectional 
Follow-up, 16 years 
Cross-sectional 
P=13% in men and 26% in women 
I=19.7/1000 in men and 25.9/1000 in women 
P=15% in men and 28% in women 
Coon et al. 1973 
Brand et al. 1988 
Criqui et al. 2003 
        
Hong Kong 6250 NA Government employment 
applicants 
Cross-sectional P=5% in men and 1% in women Colin 1972 
India 677 18–65 Male railroad workers Cross-sectional P=25% in South and 7% in North India Malhotra 1972 
Israel 4802 ≥15 General population Cross-sectional P=10% in men and 29% in women Abramson et al. 1981 
Japan 646 ≥15 Patients, hospital staff and  
residents in elderly homes 
Cross-sectional P=34% in men and 45% in women Hirai et al. 1990 
KSA 2350 ≥18 Patients Cross-sectional P=14% Bawakid et al. 2005 
Asia 
Thailand 1000 Adults NA Cross-sectional P=6% Burkitt et al. 1976 
        
Brazil  1755 >15 Patients Cross-sectional P=38% in men and 51% in women Maffei et al. 1986 South 
America Peru 2084 >16 Patients Cross-sectional P<1% Dalrymple and Crofts 1975 
        
 
Egypt 467 15–74 Female cotton workers Cross-sectional P=6% Mekky et al. 1969 
Mali 469 NA Female population Cross-sectional P=3% Rougemont 1973 
South-
Africa 
297 ≥18 Female population Cross-sectional P=8% Daynes and Beighton 1973 
Africa 
Tanzania 342 
1000 
NA 
≥18 
Rural villagers 
Outpatient clinic patients 
Cross-sectional 
Cross-sectional 
P=1% in men and 2% in women 
P=6% in men and 5% in women 
Burkitt et al. 1976 
Richardson and Dixon 1977 
        
Oceania Cook Island 377 
417 
15–64 Pukapukas  
Rarotongas 
Cross-sectional P=2% in men and 4% in women   
P=16% in men and 15% in women 
Beaglehole et al. 1975 
 
 
New 
Guinea 
1457 ≥20 Rural villagers Cross-sectional P=5% in men and <1% in women Stanhope 1975 
 
 
New 
Zealand 
721 
356 
15–64 Maoris   
Pakehas 
Cross-sectional P=33% in men and 44% in women  
P=20% in men and 38% in women  
Beaglehole et al. 1975 
 Tokelau 
Island 
786 15–64 Population sample Cross-sectional P=3% in men and 1% in women Beaglehole et al. 1975 
P, prevalence; I, incidence; GP, General Practitioner; NA, not available; KSA, Kingdom of Saudi Arabia 
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South America. In Brazil, the prevalence of varicose veins was investigated in a 
population attending the University Health Center in Botucatu for routine examination 
or for any complaint; 38% of the men and 51% of the women had varicose veins 
(Maffei et al. 1986). In Peru, 2,084 patients aged over 16 were studied and three cases 
of varicose veins were found in the group of mestizo, none of Indian origin 
(Dalrymple and Crofts 1975).
Africa. In Egypt, the prevalence of varicose veins was 6% among women 
cotton workers (Mekky et al. 1969). It was 3% (11% when reticular veins were also 
included) in Mali among the female population (n=469) of ten villages studied 
(Rougemont 1973) and 8% in South Africa in the Transkei (n=297) in women aged 18 
and over (Daynes and Beighton 1973). Both genders were studied in Tanzania, where 
6% of African men and 5% of African women aged 18 and over (n=1,000) had 
varicose veins, the slight male predominance was due to the older ages of men in the 
study population (Richardson and Dixon 1977). In a rural area in Tanzania varicose 
veins were observed in 1% men and 2% women (Burkitt et al. 1976). 
In addition, several authors have reported anecdotal evidence derived from their 
clinical observations, suggesting that varicose veins are uncommon in Africa: 
Williams (1974) worked in Uganda for 33 years and among the 100,000 patients he 
saw, not more than 50 had varicose veins. Coles (1974) stated that among 25,300 
operations performed in 19 years in a rural hospital in Sierra Leone only 11 were 
because of varicose veins. Worsfold (1974) worked in Zambian hospital for 27 years 
and he thought he “could almost count on two hands the number of patients with 
varicose veins”. Milton-Thompson (1974), after 22 years experience in a hospital and 
among outpatients in Kenya, could recall three women with varicose veins and no 
men.
Oceania. In studies from the 1970s the prevalence of varicose veins was 33% 
(in men) and 44% (in women) in New Zealand Maoris, 20% and 38% in New Zealand 
Pakehas (people of European descent), 16% and 15% in people living in Rarotonga,
2% and 4% in Pukapuka and 3% and 1% on Tokelau Island (Beaglehole et al. 1975) 
and 5%/<1% in a rural area of northern New Guinea (Stanhope 1975). 
To summarize, there is a striking geographic variation in the occurrence of 
varicose veins. Broadly, the prevalence of varicose veins in Europe and North 
America is around 10–30% in men and 25–50% in women, in Asia (excluding Japan) 
1–25%, in Africa <1–6% and <1–15% in Polynesians (20–40% in people living in 
New Zealand). The studies from South America are too few to summarize. Moreover, 
the few studies on incidence show a wide variation from 0.2 to 2 per 100 person-years. 
Geographic variation in the occurrence of varicose veins may be due to 
differences in population sampling (especially age, gender and racial mix), in varicose 
vein definition and diagnosis, and access to medical care. It can also be explained by a 
real effect of differences in lifestyle and genetic factors. Geographic variation is 
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usually construed as a strong indicator for the presence of environmentally induced 
variation (Khoury et al. 1993). However, geographic variation is consistent with 
genetic contribution as well (Khoury et al. 1993), and such does not elucidate the 
etiology of varicose veins. 
2.2.2  Age differences
In the Framingham Study age had no obvious effect on the incidence of varicose veins 
(Brand et al. 1988). In the Tampere Varicose Vein Study the highest incidence was in 
the cohort of 50-year-olds compared to the cohorts of 40 and 60-year-olds, but the 
difference was statistically significant only in women (Mäkivaara et al. 2004).
In most studies the prevalence of varicose veins increased with age in both 
genders (Weddell 1969, Coon et al. 1973, da Silva et al. 1974, Abramson et al. 1981, 
Maffei et al. 1986, Laurikka et al. 1993, Evans et al. 1999, Cesarone et al. 2002, 
Criqui et al. 2003, Kroeger et al. 2004). The same was observed in the studies of male 
Indian railroad workers (Malhotra 1972) and Japanese women (Hirai et al. 1990). An 
Italian study among elderly people (their age ranging from 66 to 96 years) reported a 
similar prevalence throughout age classes (Canonico et al. 1998). However, a Turkish 
study on persons aged 60 or over found the prevalence of varicose veins to increase 
with age in men, but not in women; the prevalence was higher in the group of 70 to 
79-year-olds compared to the group of 80+ year-old women (Komsuoglu et al. 1994).
To conclude, the incidence of varicose veins is quite stable throughout 
adulthood. The prevalence of varicose veins increases with age, because only a few 
are treated and because they are not lethal. However, it is somewhat contradictory that 
the highest incidence of varicose veins is around 2 per 100 person-years (as 
mentioned in Chapter 2.2.1.) and the prevalence of varicose veins is not higher than 
17–38% in studies of elderly people (Komsuoglu et al. 1994, Canonico et al. 1998).
2.3  Risk factors of varicose veins
2.3.1  Gender
The incidence of varicose veins was higher in women than in men aged 40–79 years, 
but no longer in the group aged 80–89 years in the Framingham Study (Brand et al. 
1988). In Finland the incidence rate was significantly higher in women in all cohorts 
studied (from 40 to 60-year-olds) (Mäkivaara et al. 2004). 
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Earlier studies also showed a higher prevalence of varicose veins in women 
than men (Weddell 1969, Coon et al. 1973, Abramson et al. 1981, Maffei et al. 1986, 
Franks et al. 1992, Laurikka et al. 1993, Sisto et al. 1995, Canonico et al. 1998, Criqui 
et al. 2003, Carpentier et al. 2004, Kroeger et al. 2004, Bawakid et al. 2005), but in 
some of them the difference between genders was not statistically significant 
(Beaglehole et al. 1975, Komsuoglu et al. 1994, Cesarone et al. 2002). There are also 
some studies which suggest that the prevalence of varicose veins is higher in men 
(Colin 1972, Stanhope 1975, Evans et al. 1999, Chiesa et al. 2005a, Chiesa et al. 
2007).
2.3.2  Weight and height
In the Framingham Study the incidence of varicose veins was higher among women 
who were obese than those who were of normal weight (Brand et al. 1988). In the 
same study the incidence was also higher for obese men, but the difference was not 
statistically significant. A follow-up study in the Netherlands also found a higher risk 
of varicose veins in the overweight group compared to the control group in women 
but not in men (Seidell et al. 1986). Only men were studied in a follow-up study in the 
USA, which did not find obesity to increase the risk for varicose veins (Scott et al. 
2004).
Many cross-sectional studies have shown an association between obesity and 
varicose veins for both sexes (Laurikka et al. 2002) or at least for women (Abramson 
et al. 1981, Sisto et al. 1995, Canonico et al. 1998, Lee et al. 2003). However, the 
studies in Switzerland (da Silva et al. 1974), Turkey (Komsuoglu et al. 1994), France 
(Carpentier et al. 2004) and Germany (Kroeger et al. 2004) did not find an obvious 
association between obesity and the prevalence of varicose veins in either sex, neither 
did the two studies in Switzerland and Japan including only female subjects (Guberan 
et al. 1973, Hirai et al. 1990).
Increasing height showed a significant relationship with trunk varices in the 
Edinburgh Vein Study both in males and females (Lee et al. 2003). In the Tampere 
Varicose Vein Study it was also an independent determinant for varicose veins in both 
sexes (Laurikka et al. 2002). Another Finnish study (Sisto et al. 1995) and a French 
study (Carpentier et al. 2004) found height significant only in women. No association 
was reported in the studies from Turkey (Komsuoglu et al. 1994), Switzerland 
(Guberan et al. 1973) and Japan (Hirai et al. 1990).
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2.3.3  Female hormones
There are physiologic states, such as pregnancy and menopause and iatrogenic states 
because of hormone medications, in which the level of female hormones in the 
circulation is far from normal and those states have been associated with varicose 
veins.
Parity. In the Framingham Study women who had had two or more pregnancies 
had a higher age-adjusted incidence of varicose veins than those who had had one or 
no pregnancies, but without statistical significance (Brand et al. 1988). Also, the 
majority of earlier prevalence studies have found a risk between varicose veins and 
parity (Arnoldi 1957, Mekky et al. 1969, Weddell 1969, Maffei et al. 1986, Sadick 
1992, Komsuoglu et al. 1994, Jawien et al. 2003, Criqui et al. 2007). Some of the 
studies reported already one pregnancy to increase the risk for developing varicose 
veins (Abramson et al. 1981, Stvrtinova et al. 1991, Canonico et al. 1998, Carpentier 
et al. 2004), whereas in the other studies more than one delivery had a significant 
influence (Hirai et al. 1990, Kroeger et al. 2004). In an Italian study the odds ratio was 
twofold in women with at least one pregnancy compared to nulliparous women 
(Carpentier et al. 2004). In Finland the multi-adjusted odds ratio for varicose veins
increased from 1.4 (95% CI: 1.0–1.9) to 3.0 (95% CI: 2.3–4.1) in women with one 
child to women with up to five children when compared to nulliparous women (Sisto 
et al. 1995).
A minority of the prevalence studies did not find a significant association 
between the prevalence of varicose veins and childbirth (Weddell 1969, Coon et al. 
1973, Guberan et al. 1973). Neither did the Edinburgh Vein Study find a risk between 
pregnancy and trunk varicosities, but less severe changes in veins were more common 
in women with a history of pregnancy (Lee et al. 1999).
Oral contraceptives. In the USA Sadick (1992) reported that patients with 
telangiectatic or varicose veins used contraceptive pills more often than those in the 
control group. The others found no association (Scott et al. 1995, Sisto et al. 1995, 
Lee et al. 2003, Kroeger et al. 2004).
Hormone replacement therapy. The results of studies on the association 
between menopausal hormone replacement therapy and varicose veins are 
inconsistent. The use of hormonal therapy increased the risk of chronic venous 
insufficiency (class 1 to 4 of CEAP) in a study on the Saudi adult population 
(Bawakid et al. 2005). Sisto and associates (1995) observed a statistically significant 
difference in the age-adjusted prevalence of varicose veins in women taking hormone 
replacement (aged 50 years and over) compared to women not exposed (35% vs. 
27%). In the Edinburgh Vein Study the use of hormone replacement therapy showed a 
significant decreased risk of trunk varices (Lee et al. 2003). In a French study of risk 
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factors of varicose veins estrogen therapy was only mentioned not to be significant 
(Carpentier et al. 2004).
Others. A higher risk for varicose veins was related to later age at menarche in 
an old Danish study (Arnoldi 1957), whereas a Swiss study could not find any 
association between the prevalence of varicose veins and the age at menarche 
(Guberan et al. 1973). According to Brand et al. (1988) women with varicose veins 
were significantly older at menopause. Two other studies could not confirm the 
relationship (Abramson et al. 1981, Lee et al. 1999). 
In an Italian study of menopausal women (n=104) the women with serum levels 
of estradiol in the upper tertile of the frequency distribution had a significantly higher 
prevalence of varicose veins than the women in the two lowest tertiles (Ciardullo et al. 
2000). A recent study on 21 varicose (CEAP??????????????????????????????????????
changed serum estradiol/testosterone ratio among men with varicose veins compared 
to healthy men (Kendler et al. 2009).
2.3.4  Occupation and physical activity
Significant associations were found with a standing posture at work and varicose 
veins in both sexes (Abramson et al. 1981, Tuchsen et al. 2000, Kroeger et al. 2004) 
or in women (Mekky et al. 1969, Sisto et al. 1995, Jawien et al. 2003, Lee et al. 2003), 
but not by all authors (Weddell 1969, Maffei et al. 1986). Working in a standing 
position was even associated with subsequent hospitalization due to varicose veins for 
both men and women in the Danish study (Tuchsen et al. 2000). Work involving 
heavy lifting was also related to the higher prevalence of varicose veins in one study 
(Weddell 1969), but not in another (Lee et al. 2003).
A study from Scotland found mainly the seated position at work to decrease the 
risk for trunk varices in women (Lee et al. 2003), whereas a study from Finland did 
not report any association between a sitting posture at work and varicose veins in 
either gender (Sisto et al. 1995). 
In the Framingham Study physical activity was assessed by the hours spent 
daily resting and doing sedentary, light, moderate, and heavy activities (Brand et al. 
1988). Compared to subjects without varicose veins, subjects with varicose veins had 
lower levels of physical activity. In a French study subjects were classified into two 
groups according to their regular exercise activity: those having less than one session 
and those with at least one session of exercise per week (Carpentier et al. 2004). Lack 
of exercise was a risk factor of varicose veins in men but not in women. A study in the 
former Czechoslovakia reported prevalence of varicose veins of all types in women 
(Stvrtinova et al. 1991). The prevalence was lower in those who were physically 
active at least once a week compared to those with no physical activity, but the 
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difference was not statistically significant. “Physical activity” was not specified in 
that study.
2.3.5  Dietary factors, alcohol consumption and smoking
Diet. Some studies reported diets deficient in fiber-rich plant foods and consequent 
constipation as risk factors for varicose veins (Cleave 1959, Dodd 1964, Burkitt 1976) 
whereas others did not find constipation to be a risk factor for varicose veins (Mekky 
et al. 1969, Abramson et al.1981, Canonico et al.1998, Criqui et al. 2007). In the 
Edinburgh Vein Study there was no association between the prevalence of trunk 
varices and dietary fiber intake in either sex (Lee et al. 2001, Lee et al. 2003). One 
study reported a significantly higher average calory intake in men with varicose veins, 
but did not find a significant difference in the distribution of various nutrients used 
(Ducimetiere et al. 1981).
Alcohol consumption. In a case-control study conducted in France alcohol abuse 
indicated a higher risk of lower limb venous insufficiency, but when adjusted for 
other potential risk factors, the result was no longer statistically significant (Gourgou 
et al. 2002). The two studies on varicose veins did not suggest alcohol consumption to 
be a significant risk factor for varicose veins (Carpentier et al. 2004, Scott et al. 2004).
Smoking. A longitudinal follow-up survey on men in Boston reported current 
smokers to be more likely to develop varicose veins than non-smokers, RR 1.3 (95% 
CI: 1.01–1.6) (Scott et al. 2004). In the Framingham Study men with varicose veins 
had higher smoking rates than those without varicose veins, but the difference was not 
observed in women (Brand et al. 1988). In a cross-sectional study from France 
smoking men had more varicose veins than men who did not smoke (Ducimetiere et 
al. 1981). A case-control study (n=3,612) carried out in France reported lower limb 
venous insufficiency to be significantly associated with tobacco smoking with dose-
effect relation in both genders. Most of the other studies observed no association 
between varicose veins and smoking (Malhotra 1972, Abramson et al. 1981, Hirai et 
al. 1990, Franks et al. 1992, Lee et al. 2003, Carpentier et al. 2004, Komsuoglu et al. 
2004). 
There are also two studies with unexpected results. In a German study of risk 
factors of varicose veins smoking indicated a protective effect on varicose veins in
both genders (Kroeger et al. 2004), whereas in a Finnish study odds ratio <1 was 
observed only in women (Sisto et al. 1995). One possible explanation for the result of 
the German study is the design; subjects who had had treatment for varicose veins 
were left out of the risk factor analysis comparing subjects with and without varicose 
veins.
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2.3.6  Heredity
A familial predisposition to varicose veins has been proposed for at least a century. 
Most of the information about the potential heredity of varicose veins has been 
obtained by taking a family history. However, responses to the questions about family 
history may be biased for many reasons. Family members were examined only in two 
studies on varicose veins (Weddell 1969, Cornu-Thenard et al. 1994) and one on 
sapheno-femoral incompetence (Belcaro 1985), the others relied on the responses of 
the study subjects. 
Clinically diagnosed varicose veins in family members. In a French study 134 
families were examined: 67 varicose veins patients and their parents and 67 controls 
and their parents. The prevalence of varicose veins for a person was 90% when both 
parents suffered form varicose veins, 25% in males and 62% in females when one 
parent was affected, and 20% when neither parent was affected. (Cornu-Thenard et al. 
1994) 
In a Welsh study subjects and their over fifteen-year-old first-degree relatives, 
in total 76 families, were examined. 23% of the relatives of subjects with clinically 
varicose veins had varicose veins, while 14% of the relatives of subjects without 
varices had them. However, the author did not consider the result conclusive because 
of the small number of families studied. (Weddell 1969)
Belcaro (1986) assessed saphenofemoral incompetence in 47 young 
asymptomatic subjects with a positive family history of varicose veins (one or both 
parents had varicose veins in the examination) and in 32 controls with a negative 
family history. The prevalence of incompetence of the sapheno-femoral junction was 
higher in subjects with positive family history of varicose veins compared to those 
with negative one. Unfortunately the study lacks many essential details to merit 
serious attention. 
Self-reported family history. The majority of earlier studies showed self-
reported positive family history to be a risk factor for varicose veins (Mekky 1969, 
Hirai et al. 1990, Stvrtinova et al. 1991, Sadick 1992, Schultz-Ehrenburg et al. 1992, 
Komsuoglu et al. 1994, Scott et al. 1995, Jawien 2003, Lee et al. 2003, Carpentier et 
al. 2004, Kroeger et al. 2004, Criqui et al. 2007) and chronic venous insufficiency 
(Gourgou et al. 2002, Bawakid et al. 2005, Chiesa et al. 2005b). However, the risk 
estimates varied considerably.
In the Edinburgh Vein Study subjects with trunk varices reported a family 
history of varicose veins more often than those without varicose veins, multi-adjusted 
odds ratio 1.5 (95% CI: 1.03–2.3) in men and 2.2 (95% CI: 1.4–3.4) in women (Lee et 
al. 2003). Some higher ratios were found in the San Diego Population Study, where
the multi-adjusted odds ratio in subjects with varicose veins (C2) was 2.9 (95% CI: 
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1.8–4.6) in men and 2.3 (95% CI: 1.8–3.1) in women (Criqui et al. 2007). In a French 
population-based study the corresponding ratios were 3.5 (95% CI: 1.9–6.5) and 3.5 
(95% CI: 2.4–5.1), respectively (Carpentier et al. 2004). Still higher adjusted odds 
ratios for family history of venous insufficiency were observed in patients with 
venous insufficiency in a case-control study from France; OR 7.2 (95% CI: 4.6–11) in 
men and 7.7 (95% CI: 5.9–9.9) in women (Gourgou et al. 2002). In a German study 
the odds ratio decreased from 5.2 (95% CI: 2.3–7.3) in case of varicose veins in both 
parents, and 3.7 (95% CI: 3–4.6) in case of paternal varices to only 2.8 (95% CI: 2.4–
3.3) in case of maternal varices only (Kroeger et al. 2004).  
Family history and early and preclinical stages of varicose veins were studied in 
the longitudinal Bochum Study. Pupils aged 10 to 12 years old at entry were 
examined at the age of 14 to 16 years and again at the age of 18 to 20 years. Only a 
weak association was reported between varicose veins and family history. Isolated 
refluxes were found at the saphenofemoral junction before visible varicose veins. 
(Schultz-Ehrenburg et al. 1992)
In contrast to the above-mentioned risk trend an Israeli study did not find a 
significant association with parental consanguinity and varicose veins when age and 
sex were controlled for (Abramson et al. 1981). Neither did an Indian study establish 
a hereditary association, but there a large majority of the subjects were unable to 
answer to the question about the family history (Malhotra 1972).
Inheritance. Almost as long as the hypothesis of the genetic predisposition to 
varicose veins has existed, the question of the mode of inheritance has been discussed. 
Arnoldi (1958) proposed the assumption of dominant heritance, whereas Troisier and 
Bayon (1937) found their observations more in line with a recessive argument. 
Niermann (1964) reported a higher degree of concordance between monozygotic 
twins (75%) than between dizygotic twins of the same sex (52%), although the 
difference was not statistically significant as the numbers involved (12 monozygotic 
and 25 dizygotic pairs of the same sex) were too low. However, because no simple
genetic mechanism was found to account for the findings Hauge and Gundersen (1969) 
proposed the hypothesis of polygenic inheritance. They assumed that the risk of 
varicose veins in a person is increased if a parent or sibling is affected, and especially 
if the affected relative is a male with early onset of varicose veins. Matousek and 
Prerovsky (1974) also studied the hypothesis of multifactorial inheritance and 
estimated the heritability of the condition to be about 50% and slightly higher for 
males than females.   
The current consensus is that both environmental and genetic factors are 
associated with the development of varicose veins (Ng et al. 2005, White and 
Ryjewski 2005, Raffetto and Kahlil 2008). Recently a British genetic twin study 
suggested one candidate gene on chromosome 16 (FOXC2) to be implicated in the 
development of varicose veins (Ng et al. 2005). Another study reported FOXC2 to be 
important for the normal development and maintenance of venous and lymphatic 
28
valves (Mellor et al. 2007). Moreover a German twin study determined the heritability 
of venous function and indicated a strong genetic influence of the venous function 
(Brinsuk et al. 2004).
2.3.7  Other potential risk factors of varicose veins
There are contradictory reports on the association between education and varicose 
veins. Lower level of education was not a risk factor for varicose veins in the follow-
up design of the Tampere Varicose Vein Study (Mäkivaara et al. 2004). Parallel 
results were reported from cross-sectional studies on men in the USA (Scott et al. 
2004) and on both genders in France (Carpentier et al. 2004). In the Edinburgh Vein 
Study lower level of education was significantly associated with an increased risk for 
trunk varices in men, but not in women (Lee et al. 2003). However, significant 
associations were reported with lower social class and varicose veins in French men 
(Ducimetiere et al. 1981), but not in the above-mentioned Scottish study (Lee et al. 
2003). 
An association between varicose veins and arterial disease and congestive
heart failure was reported in the Tampere Varicose Vein Study (Mäkivaara 2008, 
Mäkivaara et al. 2008). Japanese investigators found periodontitis to be a risk factor 
for the development of varicose veins (Kurihara et al. 2007). They observed oral 
bacteria colonization in venous valves and assessed it by means of direct infection 
result to valvular incompetence. There is also an association between varicose veins 
and deep venous thrombosis, but the direction of the association is obscure. Deep 
venous thrombosis dilates the vein in response to proximal venous obstruction and 
causes valvular incompetence and reflux (Killewich et al. 1989), which could 
predispose to varicose veins. Saarinen et al. (1999) found a reverse association, where 
varicose veins were independent risk factors of deep vein thrombosis. However, the 
varicose veins appearing after deep venous thrombosis are classified as secondary and 
are not discussed further in the present study involving primary varicose veins. 
2.4  Pathophysiology of varicose veins 
Varicose veins are a common manifestation of chronic venous insufficiency. The four 
typical findings of varicose veins include venous hypertension, reflux, incompetent 
valves and vein wall dilation. Pathologic reflux may occur in the tributary veins, 
saphenofemoral and saphenopopliteal junctions, deep venous system or perforators, 
but the base mechanism explaining where and how this disease process begins and 
progresses remains undiscovered. 
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The primary structural changes in the valves may start the pathophysiolocial 
process of varicose veins through progressive reflux to the secondary changes in the 
vein wall (Raffetto and Khalil 2008) or alternatively, or in the same time, the valves 
may become incompetent secondary to vein wall abnormality near the valve junctions 
predisposing to venous dilation, and causing the reflux (Cooper et al. 2003, Elsharawy 
et al. 2007, Raffetto and Khalil 2008).
Recent studies support the latter theory and have evinced different reasons for 
the weakness of the vein wall. Explanations evinced include endothelial cell 
dysfunction (Somers and Knaapen 2006, Raffetto and Khalil 2008), changes of the 
smooth muscle cells and extracellular matrix (collagen, elastin, proteoglycans, and 
glycoproteins) (Travers et al. 1996, Wali et al. 2002, Elsharawy et al. 2007), chronic 
inflammation (Raffetto and Khalil 2008) and abnormalities in the content and activity 
of matrix metalloproteinases (MMPs) (Gillespie et al. 2002, Kowalewski et al. 2004, 
Hobeika et al. 2007) and their tissue inhibitors (TIMPs) (Raffetto and Khalil 2008).
2.4.1  Female hormones
The effects of estrogen are generally mediated by specific receptors, which act as 
transcription factors, regulating gene expression when they are activated by estrogen 
binding. By that mechanism estrogen affects the proliferation of vascular smooth 
muscle cells and the facilitation of angiogenesis (Gungor et al. 2009). Another rapid, 
“non-genomic” pathway of estrogens has been reported. One of its effects is 
endothelium-dependent vasodilatation in the arteries (Gilligan et al. 1994, Gungor et 
al. 2009). Two subtypes of the human estrogen receptor have been identified (ER-
alpha and ER-beta) (Simoncini et al. 2004). Knaapen and associates (2005) reported 
that smooth muscle cell hypertrophy in varicose veins correlated with the expression 
of estrogen receptor-beta. 
Progesterone and progestins (the synthetic forms of progesterone) act by 
binding to progesterone receptors (Wei and Horwitz 1985). Both genomic and non-
genomic effects have been demonstrated, however, the effects on the cardiovascular 
system are unclear (Gungor et al. 2009). Either estrogen or progesterone receptors 
have been found in peripheral veins (Bergqvist et al. 1993). Mashiah et al. (1999)
reported more estrogen and progesterone receptors in varicose segments of saphenous 
vein compared to adjacent non-varicose segments of the same vein.
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2.4.2  Diet, alcohol and smoking
A low-fiber diet and concomitant constipation have been hypothesized to contribute to 
the development of varicose veins by two different mechanisms: Straining at stool 
could increase the intra-abdominal pressure and lead to valvular incompetence or 
overloaded colon could press the iliac veins and cause obstruction of venous return 
(Cleave 1959, Burkitt et al. 1976).
Alcohol has dose-dependent beneficial and harmful vascular effects, but the 
mechanisms that could explain the dual effects are not known. The ingestion of 
alcohol causes immediate vasodilation and decreasing of blood pressure, which is 
followed by a rebounding elevation of blood pressure, and alcohol drinking increases 
the risk of chronic hypertension (Bau et al. 2005). However, chronic hypertension has 
not been associated with an increased risk of varicose veins (Mäkivaara et al. 2008). 
Alcohol-induced endothelial damage or protection has been related to the synthesis or 
action of several markers, such as nitric oxide, cortisol, endothelin-1, adhesion 
molecules, tumor necrosis factor alpha, interleukin-6, C-reactive protein, and 
hemostatic factors (Bau et al. 2007).
Long-term smoking has harmful effects on the venous system, but conclusive 
evidence linking one chemical substance or a combination of these in smoke to 
vasculotoxity is not yet available. At least carbon monoxide, nicotine and oxidative 
damage are known to have harmful effects on endothelial structure and functions. 
(Jonas et al. 1992, de Sousa et al. 2005). Impaired endothelium-dependent 
vasodilatation responsiveness has been reported in the arteries (Neunteufl et al. 2002, 
de Sousa et al. 2005) and veins (Chalon et al. 2000, de Sousa et al. 2005). 
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3.  AIMS OF THE STUDY
The main aim of the present study was to evaluate potential risk factors for varicose 
veins by a longitudinal follow-up study in a general middle-aged population.
The detailed objectives of the study were:
1. To establish the effect of female hormones on varicose veins by evaluating the 
role of parity, use of hormone replacement therapy and use of oral 
contraceptives on the incidence of varicose veins in women. (I)
2. To assess if there is an association between selected lifestyle factors (daily 
bread consumption, weekly meat consumption, weekly alcohol consumption 
and smoking) and the occurrence of varicose veins. (II)
3. To estimate if subjects with positive family history of varicose veins have a 
higher risk of developing varicose veins compared to subjects with negative 
family history, and to describe misclassification bias in self-reporting of 
family history in cross-sectional studies. (III, IV)
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4.  MATERIAL AND METHODS
4.1  Study population and data collection
The Tampere Varicose Vein Study comprised three complete age-cohorts of residents 
of the city of Tampere in Finland (population 171,307 in 1989) born respectively in 
1929, 1939 and 1949, and identified from the National Population Registry. Thus the 
members of the three different cohorts were 40, 50 or 60 years old at the beginning of 
the study in 1989. The original target population consisted of 6,874 people, 3,284 men 
and 3,590 women (Figure 1). They were mailed a self-administered questionnaire in 
September, 1989. To those who did not respond to the first questionnaire, a new 
questionnaire was sent from one to two months later in order to get as a high a 
response rate as possible. The questionnaire was returned by 5,681 subjects, but 113 
responses were excluded because of missing information on varicose veins. The rest, 
a total of 5,568 subjects were regarded as the target population of the five-year 
follow-up and they were mailed an almost identical questionnaire in 1994. Due to 
death during follow-up 139 subjects could not be contacted and 78 subjects could not 
be identified in the registry. Also, in 1994 a new questionnaire was sent to those who 
did not respond to the questionnaire in the desired time.
The questionnaires in both years were, for the most part, similar and included 
items on sociodemographic factors, varicose veins, dietary habits, smoking status, 
consumption of alcohol, parity, family history of varicose veins, physical activity, use 
of medications and selected diseases diagnosed by a doctor. The questionnaires are 
provided in the Appendices.
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Figure 1. Participation in the Tampere Varicose Vein Study in 1989 and in 1994.
4.2  Survey methods
4.2.1  Definition of varicose veins 
Varicose veins were defined as “clearly visible, dilated, tortuous, and possible 
prominent subcutaneous veins of the lower extremities”. “Clearly visible” was added 
to Arnoldi’s definition (Arnoldi 1957) to help the subjects rule out any invisible leg 
complaints. The definition corresponds to class 2 in the Clinical-Etiologic-Anatomic-
Pathophysiologic (CEAP) classification system (Eklöf et al. 2004).
Clinical examination. The definition was tested in 1990 on a random sample of 
166 subjects in the cohort born in 1939. They were invited for an examination to the 
outpatient clinic of the Department of Surgery, Tampere University Hospital. The 
6874
       (3284 men/3590 women)
Target population in 1989
5568
                 (2467/3101)
            Respondents in 1989
        Target population in 1994
4903
                (2049/2854)
          Respondents in 1994
1193 non-respondents
113 excluded because of 
missing information on VV
139 deaths
78 not identified in the registry
448 non-respondents
34
subjects were examined by a surgeon (J.L.) in a warm room by inspection of the lower 
extremities and Trendelenburg tests with continuous wave Doppler reflux 
verifications. The surgeon was blind to respondents’ replies to the varicose vein 
question. All subjects with visible varicose veins were graded as varicose cases except 
those with telangiectasia as the only finding. In estimating validity, the surgeon’s 
assessment was taken as the standard. Overall sensitivity and specificity were 0.93 
and 0.93 in men and 0.92 and 0.91 in women. The estimates were poorer among 
subjects reporting positive family history of varicose veins (0.91 and 0.83) than 
among those with negative or uncertain family history (0.95 and 0.98) (Laurikka et al. 
1995).
4.2.2  Assessment of risk factors
Parity, use of contraceptive pills, use of hormone replacement therapy, daily bread 
consumption, weekly consumption of meat products, alcohol consumption, smoking 
and positive family history of varicose veins were the variables studied as potential 
risk factors of varicose veins in this study and recorded at the beginning of follow-up 
(except regarding the use of contraceptive pills, which only elicited in 1994). Based 
on self-reported data from the questionnaires the risk factors were considered as 
follows. 
Parity was defined as the number of births, also the year of the first birth was 
recorded. Women were classified into four groups according the number of births; 0, 
1, 2 and 3 or more. Subjects using hormone replacement therapy were regarded as 
users of that medication, and others as non-users. In 1994 all respondents who 
reported ever having used contraceptive pills were classified as users. Duration of 
contraceptive pill use was also recorded. Bread consumption was elicited as slices of
bread per day and classified into three categories: 0–2, 3–4 or >4 slices of bread per 
day. Consumption of meat products was elicited as a number of meals including meat 
or sausages per week and likewise classified into three categories: 0–2, 3–6 and >6 
meals of meat or sausages per week. Subjects were defined as alcohol users if they 
reported weekly alcohol consumption. Those using alcohol “not at all or occasionally” 
were defined as non-users. Subjects were classified as smokers if they had ever 
smoked cigarettes, cigars or pipes for longer than one year, including also ex-smokers. 
Family history of varicose veins was used as an indicator of heredity. This was 
elicited regarding close relatives including parents, grandparents and siblings. Family 
history was considered positive if at least one parent or sibling was affected. There 
was a response option “I do not know” and those subjects were regarded as uncertain. 
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4.2.3  Assessment of confounding factors
Age (I, II, III), sex (I, II, III), body mass index (BMI) (I, II, III), education (I, II) and 
parity (II) were treated as confounding factors. Body mass index was calculated by 
dividing the weight (kg) by the square of height (m2) and respondents were classified 
as underweight or normal weight vs. overweight with 25kg/m2 as the cut-off point. 
Level of education was elicited only in the questionnaire of 1994 and was used as a 
binary variable: comprehensive and vocational school were classified as lower 
education level, whereas university, college and high school were determined as 
higher education level. As a potential confounding factor parity was classified similar 
to that in the risk factor analysis (see 4.2.2.). 
4.3  Statistical methods
In this study the incidence of varicose veins and more specifically the multivariate-
adjusted incidence odds ratio (IOR) was used as an indicator of effect. Incidence 
observes the chronological order of cause and effect, which makes it primary indicator 
of effect in the observational studies of risk factors estimating causality. The 
prevalence odds ratio was calculated to enable comparison with earlier studies, which 
are mostly cross-sectional.
The length of follow-up was five years (an assumption based on questionnaire 
mailing times). The incidence of varicose veins was calculated in those initially free 
of varicose veins at entry, by dividing the number of new cases of varicose veins 
occurring during follow-up by the number of person-years of follow-up. The new 
varicose vein cases were assumed to appear at the midpoint of the five-year follow-up, 
i.e. their follow-up time was regarded as 2.5 person-years. The incidence rates were 
expressed as number of new cases per 1,000 person-years.
The prevalence of varicose veins was defined as the ratio of subjects ever 
having had varicose veins to all other subjects with the data on varicose veins and the 
variable in question at entry, i.e. in 1989, and it was shown in percentages (%). The 
prevalence of varicose veins by lifestyle factors and family history included only 
subjects who responded in both study-years, whereas those responding only in 1989 
were also included in the prevalence of varicose veins by parity, OC and HRT use.
Multiple logistic regression analysis was performed to find the independent 
effects of risk factors of varicose veins. The adjusted odds ratios for incidence (IOR) 
and prevalence (OR) were presented with 95% confidence intervals (CI) and were 
calculated by software packages SPSS Version 10.1 (I, III) and Version 16.0 (II, IV).
36
Subjects with missing data on specific characteristics were excluded from the 
corresponding analyses. 95% conficence intervals not including 1.0 were regarded as 
statistically significant.
The effect of bias due to misclassification in the ascertainment of family history 
of varicose veins was assessed by consistency of the data on family history classified 
according to subject’s self-reported varicose veins. The study population was 
stratified into four groups by own varicose veins (O(·,·) defined by – (without) or + 
(with) varicose veins at entry and at the end of follow-up; number of those reporting 
varicose veins neither at entry nor at the end of follow-up O(–,–), those reporting 
varicose veins both at entry and at the end O(+,+), those reporting no varicose veins at 
entry but varicose veins at the end O(–,+) and those vice versa O(+,–). Furthermore, 
in each group reported family history at entry and at the end of follow-up was 
expressed correspondingly as family frequencies; F(–,–), F(+,+), F(–,+) or F(+,–). E.g. 
F(–,–) is the number of subjects reporting no family members with varicose veins 
either at entry or at the end of the follow-up. Kappa coefficient was used to estimate 
the consistency of responses to the family history question between the two 
questionnaires in each of the O groups. Those uncertain about varicose veins or 
family history were left out. Kappa with 95% confidence intervals was calculated by 
StatXact version 4.0.1. The odds of having family members with varicose veins at 
entry was compared to the odds of having family members with varicose veins at the 
end and the association was estimated as the odds ratio from the discordant pairs, 
OR= F(+,–)/F(–,+) and tested by McNemar´s test in each of the four groups O(·,·). 
Exact Fisher's 95% confidence intervals for that ratio were calculated by WinEpi 
Describe version 1.55 Copyright J.H. Abramson 2004–2006. 
4.4  Ethical aspects
The ethics committee of Tampere University Hospital approved the study, which also 
complies with the principles of the Declaration of Helsinki. The study protocol was 
also approved by the Ethics Committee of the City of Tampere.
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5.  RESULTS
5.1  Participation rates and data
At baseline, in 1989, three age-cohorts of residents of Tampere city were mailed the 
questionnaire. The response rate was 81.0%, 75.1% (n=2,467) among men and 86.4% 
(n=3,101) among women distributed by age-cohort as shown in Figure 2. To this 
follow-up target population an almost identical questionnaire was sent five years later. 
The response rate to the second questionnaire was 88.1%, 83.1% (n=2,049) among 
men and 92.0% (n=2,854) among women. 
Follow-up respondents and those lost from follow-up were equal according to 
varicose vein status in men, but not in women. In the group of respondents a higher 
percentage of the women reported varicose veins (42.7% vs. 33.0%). Compared to 
follow-up participants, those lost from follow-up were more often smokers (75.1% vs. 
66.6% in men and 40.7% vs. 34.1% in women), alcohol users (73.4% vs. 70.4% in 
men and 40.5% vs. 38.3% in women), and had lower bread consumption (???????????
per day (48.7% vs. 44.4% in men and 61.9% vs. 58.4% in women). Those men who 
responded consumed more meat meals (>4) a week (50.5% vs. 46.6%), whereas 
women responders and non-responders were almost alike (34.2% vs. 34.8%). 
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Figure 2. Number of men (M) and women (W) and their participation by age-cohort 
and gender in 1989 and 1994.  
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At the beginning of the study 18.1% of the men and 41.9 % of the women 
reported varicose veins, whereas 2.7% of the men and 4.5% of the women were 
uncertain. Incidence of varicose veins was studied in subjects responding in both 
evaluations and did not have varicose veins at entry (n=1,253 men and 1,147 women). 
157 (52 men and 105 women) of them developed varicose veins during the five-year 
follow-up. The incidence of varicose veins in the population was 13.5 (per 1,000 
person-years).
The majority of the population belonged to the youngest cohort (Table 3). The 
greatest difference between men and women in the various lifestyle factors was in 
weekly alcohol consumption and smoking. In the incidence study 70.2% of the men 
reported weekly alcohol consumption and 63.3% a positive smoking history, the 
corresponding percentages in women were 41.7% and 34.0%. The information on 
confounding factors and risk factors was missing for 0–2.6% of the subjects (Table 3).
5.2  Female hormones and the occurrence of varicose 
veins (I)
The prevalence and incidence of varicose veins in relation to parity, oral 
contraceptives and hormone replacement therapy use are summarized in Table 4. At 
entry 82.3% of the 2,948 women reported at least one and 22.8% three or more 
pregnancies, in the incidence study the rates were 80.2% and 18.7% (Table 3) 
respectively. The prevalence of varicose veins increased with the number of births; 
33.5% in those with no births to 54.6% in those with three of more births (Table 4). 
The same was confirmed in odds ratios adjusted for age, body mass index, education 
and female hormone medications. The incidence of varicose veins did not increase as 
consistently, being 17.3 (per 1,000 person-years) in those with no births, 15.7 in those 
with one, 15.6 in those with two and 30.2 in those with three or more births. Adjusted 
incidence odds ratio, IOR was 2.0 (95% confidence interval, CI: 1.0–3.9) in the 
highest parity group compared to the nulliparous group.
In the incidence study there were 596 women who had used oral contraceptive 
pills (Table 3). Most of them were in the youngest cohort. More than half of the users 
(58.7%) had been taking contraceptive pills for at most three years, whereas the 
proportion of those who been taking contraceptive pills for at least ten years was 
14.3%. The proportion of those who had used oral contraceptive pills was greater 
(52.0%) in the incidence study than in the prevalence study (46.2%). The prevalence 
and incidence of varicose veins was lower among those who had used oral 
contraceptives, but the adjusted odds ratio was not statistically significant for 
prevalence or incidence (Table 4).
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Table 3. Number (and proportion in per cent) of individuals in the incidence study by 
confounding factors and risk factors.
Variable Incidence study population (N=2400)
Men (N=1253) Women (N=1147)
            n              %             n              %
Confounding factor
Age 40–45 571 45.6 570 49.7
50–55 380 30.3 338 29.5
60–65 302 24.1 239 20.8
Education* Higher 423 33.8 463 40.4
Lower 777 62.0 643 56.1
Other 20 1.6 20 1.7
Missing 33 2.6 21 1.8
BMI** Lower 544 43.4 700 61.0
Higher 698 55.7 431 37.6
Missing 11 0.9 16 1.4
Risk factor
Number of births 0 - - 217 18.9
1 - - 292 25.5
2 - - 413 36.0?? - - 214 18.7
Missing - - 11 1.0
OC use No - - 523 45.6
Yes - - 596 52.0
Missing - - 28 2.4
HRT use No - - 1019 88.8
Yes - - 128 11.2
Missing - - 0 0
Daily bread 0–2 163 13.0 196 17.1
consumption 3–4 399 31.8 497 43.3
>4 681 54.3 450 39.2
Missing 10 0.8 4 0.3
Weekly meat meals 0–2 150 12.0 254 22.1
3–6 857 68.4 763 66.5
>6 224 17.9 107 9.3
Missing 22 1.8 23 2.0
Weekly alcohol No 367 29.3 669 58.3
consumption Yes 879 70.2 478 41.7
Missing 7 0.6 0 0
Smoking (> 1 year) No 443 35.4 746 65.0
Yes 793 63.3 390 34.0
Missing 17 1.4 11 1.0
Family history No 544 43.3 519 45.2
Yes 429 34.2 507 44.2
Uncertain 273 21.8 121 10.5
Missing 7 0.6 0 0
*Education: higher (university, college and high school) or lower (comprehensive school and 
vocational school)
**Body mass index: lower (<25kg/m2) or higher (???????2)
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Table 4. Number of women (n) in prevalence and incidence studies, prevalent (%) and 
incident (n) cases of varicose veins, incidence rate (per 1,000 person-years) and 
adjusted* odds ratios with 95% confidence intervals (CI) for the prevalence (OR) and 
the incidence (IOR) of varicose veins by parity and hormone medications.
Risk
factor Prevalence of varicose veins Incidence of varicose veins
             n  
(N=2948)
Cases
(%)
Adj*OR (CI)           n
(N=1147)
Cases
(n)
Rate Adj* IOR (CI)
Births
0 502 33.5 1 217 18 17.3 1
1 705 39.7 1.3 (1.0–1.7) 292 22 15.7 1.0 (0.5–2.0)
2 1050 44.9 1.6 (1.2–2.1) 413 31 15.6 0.9 (0.5–1.8)?? 672 54.6 2.0 (1.5–2.7) 214 30 30.2 2.0 (1.0–3.9)
OC use
No 1540 48.1 1 523 49 19.7 1
Yes 1362 39.2 0.9 (0.8-1.1) 596 50 17.5 0.9 (0.6–1.5)
HRT use
No 2253 42.1 1 1019 92 18.9 1
Yes 379 54.1 1.3 (1.0–1.7) 128 13 21.4 1.0 (0.5–1.9)
*=adjusted for sex, age, BMI, education and the other variables in the table
At the beginning of the study 12.9% of the women reported using hormone 
replacement therapy. In those initially free from varicose veins 11.2% reported the use 
of hormone replacement medication and the majority of them were from the 50-year-
old cohort. Prevalence of varicose veins was higher in users (54.1%) than in non-users 
(42.1%), with adjusted OR 1.3 (95% CI: 1.0–1.7) (Table 4). The incidence rate was 
also higher (21.4) in those taking the medication than among non-users (18.9). 
However, after adjusting for confounding factors the effect disappeared, IOR was
exactly 1.0 with 95% confidence interval from 0.5 to 1.9.
5.3  Dietary factors, alcohol consumption, smoking 
and the occurrence of varicose veins (II)
Subjects consuming three to four slices of bread per day had a slightly higher 
prevalence of varicose veins (34.9%) than the other groups, 0–2 and >4 slices of bread 
(32.9% and 33.2%) (Table 5). In the incidence study the highest incidence of varicose 
veins (16.2 per 1,000 person-years) was in the group reporting the smallest bread 
consumption. There were no statistically significant differences in adjusted odds ratios 
of prevalence or incidence of varicose veins between different categories of bread 
consumption.
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The prevalence of varicose veins in the categories of the number of meat meals 
decreased from 39.0% in those having none to two meals of meat per week to 27.8% 
in those having more than six meals of meat a week. Incidence of varicose veins also 
decreased in the same categories of meat meals from 19.7 (per 1,000 person-years) to 
8.6. The trend was confirmed by adjusted IOR from 1 to 0.5 (95% CI: 0.3–1.1), but 
did not reach statistical significance. (Table 5) When both sexes were analyzed 
separately the trend was seen in women, IOR from 1 to 0.4 (95% CI: 0.2–0.99), but 
not in men, IOR from 1 to 0.98 (95% CI: 0.3–2.9). 
Table 5. Number of subjects (n) in prevalence and incidence studies, prevalent (%) 
and incident (n) cases of varicose veins, incidence rate (per 1,000 person-years) and 
adjusted* odds ratios with 95% confidence intervals (CI) for the prevalence (OR) and 
the incidence (IOR) of varicose veins by lifestyle factors. 
Risk factor Prevalence of varicose veins Incidence of varicose veins
n
(N=4632)
Cases
(%)
Adj*OR (CI)
(N=3644)
         n
(N=2400)
Cases
(n)
Rate Adj* IOR (CI)
(N=2202)
Daily bread
(slices)
0–2 699 32.9 1 359 28 16.2 1
3–4 1715 34.9 1.0 (0.8–1.3) 896 56 12.9 0.9 (0.5–1.4)
>4 2182 33.2 1.1 (0.9–1.4) 1131 72 13.2 1.1 (0.7–1.8)
Weekly meat 
meals
0–2 869 39.0 1 404 38 19.7 1
3–6 3096 34.0 1.0 (0.8–1.2) 1620 102 13.0 0.7 (0.5–1.1)
>6 579 27.8 0.9 (0.7–1.2) 331 14 8.6 0.5 (0.3–1.1)
Weekly 
alcohol 
consumption
No 2210 39.3 1 1036 64 12.7 1
Yes 2398 28.6 1.1 (0.9–1.2) 1357 93 14.2 1.5 (1.05–2.3)
Smoking 
> 1 year
No 2395 38.8 1 1189 76 13.2 1
Yes 2185 28.5 1.0 (0.9–1.2) 1183 77 13.5 1.3 (0.9–1.8)
*=adjusted for sex, age, BMI, education and the other variables in the table
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58.3% of the incidence study population reported weekly alcohol consumption. 
The prevalence of varicose veins in those consuming alcohol weekly erroneously 
indicated a protective effect (28.6% vs. 39.3%), whereas the findings in the follow-up 
study showed quite the opposite (Table 5). Adjusted IOR was 1.5 (95% CI: 1.05–2.3) 
in those drinking alcohol compared to those abstaining from it. The result was 
statistically significant only in women IOR 1.6 (95% CI: 1.02–2.5), but not in men 
IOR 1.4 (95% CI: 0.7–2.8) when the genders were analyzed separately.
Half of the incidence study population reported ever having smoked over a year 
(Table 3). They had slightly higher incidence of varicose veins than non-smokers, 
with IOR 1.3 (95% CI: 0.9–1.8) (Table 5). However, the difference was not 
statistically significant. A stronger effect was seen in further analysis in those smokers 
who reported the amount of smoking at least 15 cigarettes/cigars/pipefuls a day 
(n=466), IOR 1.8 (95% CI: 1.1–2.8) compared to non-smokers. The prevalence of 
varicose veins in smokers (28.5%) was lower than in non-smokers (38.8%) indicating 
the opposite result as was now found in the follow-up (Table 5).
5.4  Family history and the occurrence of varicose 
veins (III, IV)
The information on family history of varicose veins was missing from only 15 men 
and 7 women at entry. The numbers of subjects responding “do not know” about 
family history were greater among men than among women both at entry (24.0% vs. 
13.6%) and among those followed up (21.8% vs. 10.5%). The prevalence of varicose 
veins was 47.5% in those reporting positive and 15.0 % in those with negative family 
history of varicose veins (Table 6). According to prevalence, family history indicated 
a high risk of varicose veins. Age and body mass index adjusted OR was 5.3 (95% CI:
4.5–6.3). The incidence of varicose veins in those with positive family history was 
16.5 per 1,000 person-years, 10.0 in men and 22.1 in women. Adjusted IOR was 1.6 
(95% CI: 1.1–2.3), 1.4 (95% CI: 0.7–2.6) in men and 1.8 (95% CI: 1.1–2.8) in women.
The smaller multi-adjusted odds ratio of 1.6 based on the follow-up compared 
to the 5.3 based on the prevalence is an indication of misclassification due to recall 
bias and other factors. Therefore we further studied the potential of misclassification 
to be differential by comparing the effect of changes in the subject’s varicose veins 
status on the information on family history. In the whole population odds ratio was 
0.63, i.e. prevalence of positive family history became more uncommon during 
follow-up (Table 7). However, it varied from 0.14 (if a subject’s own varicose veins 
disappeared for some reason) to 6.00 (if a subject developed varicose veins during 
follow-up). 
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Table 6. Number of subjects (n) in prevalence and incidence studies, prevalent (%) 
and incident (n) cases of varicose veins and adjusted* odds ratios with 95% 
confidence intervals (CI) for prevalence (OR) and incidence (IOR) of varicose veins 
by family history.
Risk factor Prevalence of varicose veins Incidence of varicose veins
n Cases 
(%)
Adj*OR (CI)  n Cases
(n)
Rate/
1000
Adj* IOR (CI)
Family history
  All No 1550 15.0 1 1063 54 10.4 1
Yes 2254 47.5 5.3 (4.5–6.3) 936 74 16.5 1.6 (1.1–2.3)
Uncertain 809 31.6 3.0 (2.4–3.8) 394 29 15.3 1.6 (1.0–2.6)
  Men No 719 6.7 1 544 20 7.5 1
Yes 766 30.3 6.6 (4.7–9.3) 429 21 10.0 1.4 (0.7–2.6)
Uncertain 461 19.3 3.4 (2.3–5.0) 273 11 8.2 1.0 (0.4–2.1)
  Women No 831 22.3 1 519 34 13.5 1
Yes 1488 56.4 4.9 (4.0–6.0) 507 53 22.1 1.8 (1.1–2.8)
Uncertain 348 48.0 3.0 (2.2–3.9) 121 18 32.1 2.3 (1.2–4.4)
*= adjusted for age and body mass index (BMI as a dichotomous variable, with 25 kg/m2 as a cut-off 
point), in all-group also with sex
Table 7. Number of subjects (n) by self-reported own status of varicose veins at entry 
and at the end of follow-up (O (·,·)) and by family history of varicose veins at entry 
and at the end of follow-up (F (·,·)) with kappa coefficients of consistency and odds 
ratios of family history by own status of varicose veins.
n F(–,–) F(–,+) F(+,–) F(+,+) Kappa 95% CI* OR  95% CI*
O(–,–) 1380 611 53 103 613 0.77 0.74–0.81 0.51 0.41–0.61
O(–,+) 101 21 12 2 66 0.66 0.50–0.82 6.00 2.01–47.8
O(+,–) 56 15 1 7 33 0.69 0.49–0.88 0.14 0.01–0.58
O(+,+) 909 97 25 33 754 0.73 0.67–0.80 0.76 0.57–0.89
Total 2446 744 91 145 1466 0.79 0.76–0.81 0.63 0.54–0.71
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The incidence rate of varicose veins in subjects with no varicose veins at entry 
varied between the four family history categories (F (·,·)). It was 4.1 (95% CI: 2.1–7.1) 
in those who reported positive family history only at the end of follow-up F(–,+) and 
lowest 0.4 (95% CI: 0.1–1.4) in those reporting positive family history only at entry 
F(+,–). Incidence rate was 0.7 (95% CI: 0.4–1.0) in F(–,–) group and 2.0 (95% CI: 
1.6–2.6) in F(+,+) group.
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6.  DISCUSSION
6.1  Study population and methods
The study population was a representative sample of Finns in middle and late 
adulthood living in a middle-sized Finnish city. Altogether the response rates were 
unusually high and much higher than in most postal questionnaire studies published in
medical journals (approximately 60%) (Asch et al. 1997). The response rates were 
higher among women (86% in the first and 92% in the second questionnaire) than 
among men (75% and 83% respectively) and higher in the older cohorts compared to 
the youngest ones (Figure 2). Previous research has demonstrated that written 
reminders (Asch et al. 1997, Edwards et al. 2002, Ronckers et al. 2004) and monetary 
incentives (Church 1993, Edwards et al. 2002) increase response rates, and the former 
was used in the present study. Other explanations for the high response rates are that 
the questionnaire was only four pages long and the material was collected in the 
1990s. It is known that response to a shorter questionnaire is more likely than to a 
longer one (Edwards et al. 2002, Ronckers et al. 2004) and that participation in 
surveys in general has declined in recent decades (Morton et al. 2006). 
However, the response rates in men were lower than those in women and lowest 
in the youngest cohort in both sexes (Figure 2). Common reasons for non-response are 
a feeling of lack of personal benefit from responding (Bakke et al. 1990) and a 
negative attitude to the health care system (Janzon et al. 1986). A low response rate in 
a questionnaire study may increase the risk of selection bias (Rothman and Greenland 
1998). A higher response rate in men would have resulted in narrower confidence 
intervals and better statistical power. Among women the evidence of the selection bias 
is the difference in varicose veins status in those among follow-up (42.7%) compared 
to those lost from follow-up (33.0%). The response rate in women was very good and 
the proportion of non-respondents small, which has no substantial effect on the 
outcomes of the study, however. 
Respondents also differed from non-respondents according to lifestyle factors. 
According to earlier studies, it is a common finding that a higher proportion of non-
respondents are smokers than of respondents (Kelsey et al. 1986), as indeed in our 
study. It is assumed that non-participation may affect the generalizability of the results 
(Kelsey et al. 1986), which means that the occurrence of varicose veins in our study 
may be slightly lower than in the entire population invited to participate.
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The terminology used to define and classify varicose veins in subjects is not 
consistent. Specifically the comparison with earlier studies is challenging due to the 
lack of precision in diagnosis before the CEAP classification. Several overlapping 
clinical manifestations of the same disease process have been defined as “varicose 
veins”. In this study we used the definition proposed by Arnoldi (1957), which 
concurs with clinical class 2 in the CEAP classification, the latest consensus statement 
on classification of chronic venous disorders (Eklöf et al. 2004). In the sub-sample 
study the specificity (0.92) and sensitivity (0.93) of the self-reported diagnosis was 
fairly good but less so in those with positive family history (0.83 and 0.91 
respectively). The differences between respondents initially raised the question about 
bias in self-reported family history, which was then studied further as one aim of the 
dissertation and discussed in more detailed in Chapter 5.4.
We collected the information on the study population by self-administered 
postal questionnaires, which are prone to biased information. The responses may be 
affected by anyone around, such as other family members. Also, complicated
questions are not always well understood by the respondent. (Kelsey et al. 1986)
Earlier studies have also compared the self-reporting of varicose veins to 
clinical examination of varicose veins and the results have varied widely. In an
English study the sensitivity (76%) and specificity (86%) were somewhat less than in 
our study (Franks et al. 1992). In an Italian study on elderly people there was a good 
correspondence between responses and clinical findings (29.6% reported vs. 27.4% 
positive in the clinical examination) (Canonico et al. 1998). Poorer results were 
reported from a study in Israel; the sensitivity of the interview data was only 47% in 
men and 67% in women, hence the specificity was 95% in men and 85% in women 
(Abramson et al. 1981). In the study by Weddell (1969) of those with varicose veins, 
52% of the observations by the rest of the family proved to be correct and 48% did not, 
while in those without varicose veins 93% were correct and 7% were not. In 
conclusion, compared to earlier studies misclassification of varicose veins in the 
present study was likely to be low.
There are also some weaknesses in questionnaires themselves. When potential 
risk factors are studied, it is important to classify subjects already at entry into those 
who are exposed and to those who are not. Here, education and the lifetime use of oral 
contraceptive pills were only elicited in 1994. However, it may be assumed that 
education has changed little in middle-aged population during follow-up or that there 
were not many new contraceptive users after 1989 among 40-year-olds not to mention 
women in older cohorts. Therefore information on education and the use of oral 
contraceptive pills would have been essentially the same if already elicited at study 
entry in 1989 and consequently did not affect the number of subjects exposed. 
We used body mass index >25kg/m2 as an indicator of overweight. It is known 
that under-reporting of weight (Villanueva 2001, Gorber et al. 2007) and over-
reporting of height (Gorber et al. 2007) are common. In Finland overweight also 
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increases with age in working population (Lahti-Koski et al. 2000). In our study 58% 
of the men and 45% of the women were overweight at entry according to self-reported 
weight and height. There is some under-reporting if the proportions are compared to 
the National FINRISK Study in Finland in 1987, where the subjects were measured 
by trained nurses. According to this research body mass index was ?25kg/m2 in 64% 
of men aged 35–44 years and 74% of men aged 45–54 years. The corresponding 
percentages were 41 and 62 in women (Lahti-Koski et al. 2000). There was some 
variation in body mass index between the two questionnaires; the category was 
changed for 14% of the men and 15% of the women during the follow-up and three-
quarters of them from the lower category of body mass index to the higher one in both 
genders. We used body mass index as a binary variable with 25kg/m2 as a cut-off 
point. Multivariate analyses were repeated with changing the classification of body 
mass index (e.g. BMI classified in three categories or 30kg/m2 as a cut-off point), but 
it did not significantly change the results.
Furthermore, we did not elicit passive smoking, which may have increased the 
number of those exposed to the effects of smoking, especially in women. However, 
there are no studies on the effects of passive smoking on varicose veins, i.e. it is an 
open question whether there are any effects at all. With regard to alcohol consumption, 
it is commonly known that the consumption of alcohol is underreported (Feunekes et 
al. 1999). However, we classified subjects only crudely into weekly users and non-
users of alcohol, thus this hardly biased the results in our study. Also, the use of a 
standardized food frequency questionnaire would have been more valid for collecting 
data on diet. As diet was not the main interest of the Tampere Varicose Vein Study, 
the crude and limited information related to all possible risk indicators of varicose 
veins was deemed sufficient at the planning phase of our study. We also intended to 
keep the requested data set small in order to achieve the highest possible response rate. 
The effect of crude questioning is to reduce the estimate of effect. Therefore, it is 
unlikely that the result on meat can be accounted for bias from this source. 
We studied both the prevalence and incidence of varicose veins by different 
potential risk factors. Prevalence as a measure of disease occurrence gives a good 
picture of the total burden of the condition in a population, but for etiological 
purposes incidence is better. In a longitudinal study with multiple assessment time-
points the risk factor (potential cause) can be better controlled and demonstrated to 
precede the effect. Therefore, the main emphasis in the results and in the discussion is 
on the incidences found by the five-year follow-up design. 
A methodological weakness is our assessment of varicose veins at only two 
time-points during follow-up, at entry and at the end of the five-year period, thus the 
exact time point for the appearance of varicose veins is not known. We assumed that 
new varicose veins occurred on average at the midpoint of the follow-up period, thus 
the person-years for incident cases were approximations. This may have caused some 
inaccuracy in the estimates of incidence. However, the effect of this should be equal 
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on both sides of the selected mid-point. Also, because of the crude classification of 
the confounding factors in the multivariate analysis, there may be some residual 
confounding. 
6.2  Results
6.2.1  Occurrence of varicose veins
There is a note worthy variation worldwide in the reports of the occurrence of 
varicose veins. Only three studies have estimated the incidence of varicose veins in 
developed countries and none in developing countries. In Finland, the incidence of 
varicose veins, 13.5 per 1,000 person-years (Mäkivaara et al. 2004) is at the medium 
level compared to the longitudinal follow-up studies in Italy (Cesarone et al. 2002) 
and the USA (Brand et al. 1988). 
The prevalence estimates from Finland (18% in men and 42% in women in the 
Tampere Varicose Vein Study, and 7% in men and 25% in women in the national 
health survey) are also on average level among other industrialized countries. The 
highest estimates in Europe have been reported in Italy (Chiesa et al. 2007). Much 
lower rates have been reported from developing countries, but some facts must be 
kept in mind when comparing the results with those from developed countries: Most 
of the literature is old, for example all of the studies from Africa were completed in 
the 1960s and 1970s. At that time, life expectancy there was even lower than 
nowadays and is still much lower than in western countries. Typically, the reported 
mean ages for study populations are also lower. In the case of varicose veins, which 
occur throughout adulthood, the cumulative prevalence is lower in younger population.
However, even today the situation may have changed because of the increased life 
expectancy and changes in lifestyle in developing countries, too.
There are two population-based studies from Asia. Based on the results the 
prevalence of varicose veins is 14% in adult population of the Kingdom of Saudi 
Arabia (Bawakid et al. 2005) and 21% in the population (mainly immigrants) of 
western Jerusalem (Abramson et al. 1981). The few other studies from Asia are from 
selected study populations, e.g. occupational groups with widely disparate results. In 
future, especially in the world’s most densely populated continent, well-designed 
population-based studies are needed to ascertain the magnitude of the problem.
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6.2.2   Female hormones and varicose veins
In the present study, three or more births doubled the risk of varicose veins compared 
to that of nulliparous women. Instead, the incidence of varicose veins was not 
increased in women with one, or in women with two births compared to women who 
have not given birth. It was not self-evident that there would be a higher incidence in 
multiparous (??? ???????? ??????-aged women, who had had their pregnancies years 
before. Our result is almost similar to that of the Framingham Study, where women 
(aged 40–89) with two or more pregnancies had a higher incidence of varicose veins 
compared to those with one or no pregnancies, but without statistical significance 
(Brand et al. 1988). 
The prevalence of varicose veins increased with increasing number of 
pregnancies, and one pregnancy was already associated with a significantly higher 
risk (OR 1.3). Higher risk in those with at least one pregnancy has also been reported 
in elderly populations in Italy (aged 65+) (Canonico et al. 1998) and in Turkey (aged 
60+) (Komsuoglu et al. 1994), and in a younger study population (aged 18 years and 
older) in France (Carpentier et al. 2004). There are also a couple of studies reporting 
parity not to be associated with varicose veins (Weddell 1969, Coon et al. 1973, 
Guberan et al. 1973) or trunk varices (Lee et al. 1999).
The estimates of the risk in women with one or two births differed between 
prevalence and incidence design in our study. One explanation could be that a genetic 
factor may contribute more in young age to the development of varicose veins. 
Subjects with varicose veins at entry were only included in the prevalence analysis. 
Nor were the women who only contracted the disease in middle age in spite of one or 
two births, so susceptible in middle age. The threshold for significantly increased risk 
was three births.
Pregnancy is associated with a number of physiological changes which may 
contribute to the development of varicose veins. The mechanisms are unclear, but 
probably more than one factor is involved. The hormonal changes are dramatic, in 
which estradiol and progesterone play a major role with levels elevated 10-fold 
compared to non-pregnant state. More estrogen (Mashiah. et al. 1999, Knaapen et al. 
2005) and progesterone receptors have been found in the varicose part of saphenous 
vein (Mashiah et al. 1999), which favors the idea of hormone influence on varicose 
veins. The major increase in estradiol in serum occurs within the first 16 gestational 
weeks followed by a further moderate increase by term, whereas the progesterone 
level increases more gradually (O’Leary et al. 1991). Recent studies have also 
reported relaxin to have vasodilatory potential and possibly also to promote 
angiogenesis. In pregnancy it is secreted by the corpus luteum, reaching the highest 
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level in the first trimester and having the effect of softening the birth canal. 
(Dschietzig et al. 2006)
Early in pregnancy there is a significant increase in plasma volume (Bernstein 
et al. 2001) and blood flow (Fawer et al. 1978), also a significant dilatation of the 
veins of lower extremities either in women with normal (Cordts et al. 1996, Pemble
2007) or varicose veins (Sparey et al. 1999). However, the results of the above-
mentioned studies were inconsistent with respect to the reversibility of the pregnancy-
induced dilatation. The latest study in primipara women (n=39 gravida, n=69 
nulliparous controls) found that the reversal of the dilation after delivery is not 
complete (Pemble 2007) as was earlier assumed on the basis of studies with smaller 
sample sizes (n=8 and n=11) (Cordts et al. 1996, Sparey et al. 1999). This new finding 
indicates permanent structural changes in the veins, which may deteriorate in 
subsequent pregnancies and explain the increased risk of developing varicose veins in 
multiparous women (Pemble 2007). 
In the second and third trimesters the enlarging gravid uterus may compress the 
inferior vena cava and iliac veins, reducing venous return from the lower extremities, 
which increases the venous pressure and could contribute to the development of 
varicose veins during pregnancy (Arnoldi 1957). However, that theory disagrees with 
the understanding that most varicose veins already appear in the first trimester 
(Arnoldi 1957, Dodd and Cockett 1976, Schadeck and Vin 1984). 
To conclude, the hormonal changes and the increased blood volume and flow, 
concurrently with the appearance of varicose veins in the early stages of pregnancy 
suggests their involvement in the development of varicose veins. The measurable 
changes during pregnancy are mostly temporary, but at least small structural changes 
in the vein wall could be permanent, leading to the subsequent development of 
varicose veins. The present study showed that middle-aged women who have had at 
least three pregnancies have a two-fold risk of varicose veins compared to nulliparous 
women.
One aim of the present study was to assess if the same hormones in the form of 
contraceptive pills or hormone replacement therapy have an effect on the incidence of 
varicose veins. Estrogen and progesterone (or their derivatives), or progesterone alone, 
are used in contraceptive pills, whereas postmenopausal hormone therapy consists of 
estrogen alone, or in combination with progesterone (if a woman has not had a 
hysterectomy). Half of the women (52%) in the follow-up had used contraceptive pills 
and 11% hormone replacement therapy. Unfortunately, we did not have the 
opportunity to ascertain the type of contraceptive pills or hormone replacement 
therapy used. 
Studies on hormonal medications and varicose veins are rare. Most of the few 
studies on oral contraceptive use and varicose veins have found no association. Our 
results concur with these. Only a study of 500 telangiectatic or varicose veins patients 
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and 500 healthy controls implicated oral contraceptive use as a predisposing factor to 
the development of telangiectatic and varicose veins (Sadick 1992). 
We did not find a significant difference in the incidence of varicose veins 
between the users and non-users of hormone replacement therapy. The number of 
hormone replacement users in our study population was quite small, partly due to the 
age-cohorts included. The average age at menopause is 51 years (Greendale et al. 
1999), and two cohorts were younger at the beginning of the follow-up. However, 
there are no previous longitudinal studies against which to compare our results. 
In the present study the prevalence of varicose veins was somewhat increased in 
women who had used hormone replacement therapy. A parallel result was reported in 
a cross-sectional study from Finland (Sisto et al. 1995), where a significantly higher 
prevalence was observed in women aged 50 years and over. Similarly, a Saudi-
Arabian study performed a higher risk of varicose veins among users of hormone 
replacement therapy compared to non-users (OR 1.5 (95% CI: 1.2–1.9)), but they 
included subjects with a wider spectrum of venous insufficiency (CEAP 1–4) in their 
study. The relationship was opposite in the Edinburgh Vein Study, where subjects 
using hormone replacement therapy had a decreased risk of trunk varices, with odds 
ratio of 0.48 (95% CI: 0.25–0.91) (Lee et al. 2003).
If there is an association between varicose veins and female hormones, the 
number of lifetime cycles of menstruation could be meaningful. We could then 
assume an increase in the prevalence of varicose veins among women with a long 
duration of menstrual life, that is, an early age of menarche and a late onset of 
menopause. Only one of the few studies has supported this conjecture. In the 
Framingham Study, women with varicose veins were older at menopause (Brand et al. 
1988). If Brand et al. (1988) are right, and menopause has an effect on varicose veins, 
menopause should have been considered a confounding factor. In this respect, due to 
lack of information on menopause, it is possible that no potential association was 
found.
The information on menopause would also have made it possible to study the 
potential association in detail, since the latest data on an association between hormone 
replacement therapy and cardiovascular disease have suggested the timing of the 
treatment and the type of progestin used to underly the contradictory statements on the 
effects of hormone replacement therapy. There are suggestions that should hormone 
replacement medication be used in the early postmenopausal years, the effect on 
vascular wall due to the inhibition of atherosclerosis may be protective, whereas in 
late menopause adverse effects may develop. (Gungor et al. 2009) However, the 
effects of hormone replacement therapy on the vein walls could be different from the 
effects on arteries.
In conclusion, there was no association between external female hormones and 
varicose veins in our study. Further studies are needed to consider the most recent 
information from the arterial side on the study design. However, the considerable 
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difference in the occurrence of varicose veins between sexes could not be explained 
by female hormones alone.
6.2.3  Dietary factors, alcohol consumption, smoking and varicose veins
There are some epidemiologic studies on the possible association between lifestyle 
factors and varicose veins. The lifestyle factors included in our study were daily bread 
consumption, weekly meat consumption, alcohol consumption and smoking (of 
cigarettes, cigars or pipes). 
We studied the association between varicose veins and dietary fiber by asking 
daily bread use, and found no association. In the Edinburgh Vein Study fiber intake 
was assessed with a specific questionnaire, and likewise found no association between 
trunk varices and dietary fiber (Lee et al. 2003). Earlier speculations on the role of 
diet in the etiology of varicose veins have been raised in order to explain the 
differences in the occurrence of varicose veins between developing and developed 
countries (Cleave 1959, Dodd 1964, Burkitt 1972). Western diet has been blamed for 
deficiency in fiber. Subsequent constipation and straining at stool could increase intra-
abdominal pressure and valvular incompetence and as such increase the risk for 
varicose veins. However, the four studies have not succeeded in confirming the 
association between varicose veins and constipation (Mekky et al. 1969, Abramson et 
al.1981, Canonico et al.1998, Criqui et al. 2007).
The present study also hypothesized the intake of meat in the etiology of 
varicose veins. Meat is the main source of protein in a Finnish diet providing one third 
of the daily protein intake (Paturi et al. 2008). Interestingly, the results implied an 
inverse association between the frequency of meat intake and varicose veins, but it 
was statistically significant only in women. There was a trend-like dose-response 
gradient between meat consumption and varicose veins. To the best of our knowledge, 
one study has investigated the association between varicose veins and protein intake, 
but reported no relationship (Ducimetiere et al. 1981).
It is difficult to put an accurate interpretation on this finding. We adjusted for 
age, body mass index and education, but lifestyle is dependent on several other 
background characteristics, too. These factors could be the true protective factors 
behind abundant meat consumption. 
The three existing studies on alcohol consumption and varicose veins 
(Carpentier et al. 2004, Scott et al. 2004) or venous insufficiency (Gourgou et al. 2002) 
have analyzed alcohol consumption as a bivariate trait, but the cut-off points have 
been different. The lowest limit was >10g per week in the French study (Carpentier et 
al. 2004) and this classification was closest to the classification in our study. The two 
others were ???????????????????????????????????????????????????????????????????????
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per day in women (Gourgou et al. 2002). In any case, none of these cross-sectional 
studies found any association between alcohol consumption and varicose veins.
In the present study we were able to show that weekly alcohol consumption 
contributes to the incidence of varicose veins. The risk in those drinking alcohol 
weekly was 1.5-fold compared to non-drinkers (or those drinking alcohol 
occasionally). However, the finding was statistically significant only in women. It is 
known that alcohol consumption affects the vascular system (Bau et al. 2005, Bau et 
al. 2007) but in which way and on exactly which part is still uncertain. 
The crude, non-adjusted rates even indicated a protective effect of alcohol 
consumption. Studies based solely on prevalence estimates showed no association 
between varicose veins and alcohol consumption. The fact that there is a difference 
between the results of incidence and prevalence studies emphasizes the importance of 
adequate study methods.
By far the most studied lifestyle factor is smoking, and with inconsistent results 
(Brand et al. 1988, Sisto et al. 1995, Lee et al. 2003, Kroeger et al. 2004, Scott et al. 
2004). The only existing follow-up study on smoking and varicose veins detected an 
elevated risk in current smokers (RR 1.3) (Scott et al. 2004). We agree with that result. 
In our study, those who had ever smoked at least over a year had IOR 1.3 compared to 
non-smokers, however, the result was not statistically significant. Among heavy 
smokers (??????????????????????????????????????????????????????????????????????????
clearer. The risk of varicose veins in those increased compared to non-smokers, IOR 
1.8, with statistical significance. 
A case-control study in France reported a dose-effect relation of tobacco 
smoking on lower limb venous insufficiency to be significantly associated with 
adjusted odds ratio from 1.4 (95% CI: 0.9–2.2) for 10-19 cigarettes/day to 2.1 (95% 
CI: 1.4–3.2) for ??????????????????????????and from odds ratio 1.8 (95% CI: 1.3–2.3) 
to 2.4 (95% CI: 1.7–3.4) in women, respectively (Gourgou et al. 2002).
The mechanisms responsible for the harmful effects of tobacco on the venous 
system are not exactly known. However, studies on arteries have published a strong 
association between smoking and peripheral arterial disease (Willigendael et al. 2004, 
Agarwal 2009). The cross-sectional results did not show an increased risk of smoking 
on varicose veins. Instead, the prevalence of varicose veins was higher in non-
smokers (39%) compared to smokers (29%). 
In the present study alcohol consumption and small amount of meat in diet 
increased the risk of varicose veins in women, while smoking seemed to be a risk 
factor in both men and women. The associations were found in the follow-up design,
and differed from the prevalence results, particularly in alcohol consumption and 
smoking. Follow-up design is more credible for studying risk factors. The data of the 
risk factors are observed at entry and the disease is detected in subjects originally free 
of it during the subsequent follow-up, hence information on exposure is less biased. In 
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addition, only longitudinal design can assess a temporal relationship, which is 
essential in assessing causality and in detecting risk factors.
6.2.4  Heredity and varicose veins
Positive family history is considered one of the main risk factors for varicose veins 
based on cross-sectional studies with prevalence estimates (Komsuoglu et al. 1994, 
Lee et al. 2003, Carpentier et al. 2004, Kroeger et al. 2004), but the estimates of the 
magnitude of the risk vary a lot in published data. The few studies on genes support a 
genetic influence on venous function (Brinsuk et al. 2004) and on the etiology of 
varicose veins (Ng et al. 2005). However, positive family history does not 
automatically mean a genetic cause. The family usually shares the same environment 
and lifestyle. They may even have the same occupations and other ways of life 
exposing them to varicose veins, which could lead to another kind of family-linked 
cause.
Most studies have relied on the information obtained from study subjects, not 
consulting or examining relatives themselves. Neither did we have the opportunity to 
examine the relatives. The validity of the self-reported information on relatives is 
open to question. A person who has varicose veins is more likely to know whether he 
or she has a relative who also suffers from the condition. However, in Finland the 
traditional lifestyle includes sauna bathing, which makes direct observation of family 
members acceptable and easy. Therefore, Finns may know the family history of 
varicose veins slightly better than people in many other countries. 
We had a unique opportunity to assess familial predisposition based on a 
follow-up design. Only those who did not have varicose veins at entry were included 
in the incidence study. The family history was elicited at entry, so it was not affected 
by the respondent’s own varicose vein status during follow-up. If at least one of the 
first-degree relatives from an originally healthy family was reported to have varicose 
veins at the end of follow-up it was enough to change the classification from a 
negative family history to a positive one. On the other hand, a new affected relative 
did not cause any change in the classification in subjects whose family history was 
already considered positive at entry. The number of men uncertain about family 
history was greater than the number of uncertain women, and the IOR of incidence 
was also lower in uncertain men (1.0) than in uncertain women (2.3). Women could 
be more interested in health-related factors in the family, and that could explain the 
greater uncertainty of men, whereas the lower incidence of varicose veins in uncertain 
men compared to uncertain women is more difficult to explain. One explanation could 
be that uncertain women already had varicose veins at entry, but they did not know it 
– neither did they know of a family history of varicose veins, but after completing up 
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the questionnaire they became interested in the subject and noticed their own varicose 
veins, too. Nor could the possibility of chance variation be ruled out.
We found the risk in those with positive family history to be 1.6-fold compared 
to those with negative family history. When both genders were analyzed separately, 
the odds ratio was 1.8 in women and 1.4 in men, but without statistical significance. 
There are no earlier longitudinal results to compare our findings with. The risk 
estimates are at the same level as cross-sectional results in the Edinburgh Vein Study 
(Lee et al. 2003). They reported an adjusted odds ratio of 1.5 in men and 2.2 in 
women. Most other cross-sectional studies have reported much higher estimates of the 
risk (Gourgou et al. 2002, Carpentier et al. 2004, Kroeger et al. 2004).
The difference warranted us to study this issue further in order to explain at 
least some of the difference. We studied potential misclassification bias by comparing 
subjects’ own varicose vein status or changes in it with the self-reported family 
history of the whole study population in the two questionnaires. We also included 
those who had varicose veins at entry. We found the consistency of family history of 
varicose veins to be higher if subjects’ own self-reported status of varicose veins was 
consistent and less if the self-reported status of varicose veins was different in the 
questionnaires. For example, the highest odds ratio (6.00) was observed in those who 
developed varicose veins during follow-up. The maximal ratio of odds ratios for 
remembering family history was about 40 (6.00 versus 0.14), indicating substantial 
recall bias. 
On the other hand, the incidence rate of varicose veins varied from 0.4 to 4.1 
(per 100 person-years) depending on how the subject recalled the family history. The 
variation is difficult to explain by a real effect, it is rather explained by observer bias. 
A subject becomes more sensitive to his/her own varicose veins if there is a strong 
family predisposition. 
An overall decrease in the prevalence of family history between the two 
questionnaires was also observed. This may be because of bias or it may be true: The 
relatives with varicose veins may have died during follow-up, but such selection is 
unlikely because varicose veins as such are not lethal. On the other hand, there is a 
chance that subjects want to forget their varicose veins after treatment, as well as the 
varicose veins in the rest of the family. It is more likely that new varicose veins 
appeared during the follow-up in the relatives, too, and if anything, the odds ratios 
would be >1. 
An explanation for the difference in results between cross-sectional and follow-
up studies is that subjects with strong genetic predisposition to varicose veins may 
have acquired them at a younger age. In that case, in our study design they were 
included in the cross-sectional population, where they increased the prevalence 
estimate and were excluded from follow-up. However, in the eight-year Bochum 
Study on pupils aged 10–12 years at entry, only a weak association between family 
history and occurrence of varicose veins was found (Schultz-Ehrenburg et al. 1992). 
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Overall, family history is a risk factor or a predictor of varicose veins, 
particularly in women. According to our results the risk is not as high as earlier 
assumed in the literature. Differential misclassification bias in ascertainment can 
explain part of the very high risk estimates in cross-sectional studies. 
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7.  SUMMARY AND CONCLUSIONS 
The etiology of varicose veins is unclear. The present knowledge of risk factors of 
varicose veins is mainly based on cross-sectional studies with prevalence estimates. 
Cross-sectional studies lack follow-up, causing difficulty in assessing the temporal 
relationship essential to determining cause and effect. The purpose of the present 
study was to assess potential risk factors of varicose veins in a five-year follow-up 
study in middle-aged men and women. Three complete cohorts of 40, 50 and 60 year-
old inhabitants of the Finnish city of Tampere were included in the study, of whom 
4,903 (71%) responded both at entry and at the end of follow-up. Incidence was 
studied in subjects free of varicose veins at entry. Prevalence rates were established 
for purposes of comparison. The potential risk factors studied were parity, oral 
contraceptives, hormone replacement therapy, diet, alcohol consumption, smoking 
and family history of varicose veins. 
The major findings and conclusions are, 
1. The incidence of varicose veins increases significantly in women with three or 
more births compared to nulliparous women. The risk is twofold. Oral 
contraceptives or hormone replacement therapy did not have an obvious effect 
on the incidence of varicose veins in the present study. 
2. Alcohol consumption is a risk factor of varicose veins, particularly in women.  
Smoking is likely to increase the risk of varicose veins, with a stronger effect 
on heavier smokers. More meat in a diet may protect against varicose veins, 
especially in women. Dietary fiber intake does not contribute to the occurrence 
of varicose veins. However, it is possible that there are some other lifestyle or 
background factors which are the true risk factors or protective factors behind 
those now reported in our results. 
3. The incidence of varicose veins is 1.6-fold in those with positive family 
history of varicose veins compared to those with negative family history. The 
risk is not as high as commonly proposed in the literature, consisting mainly of 
cross-sectional studies with prevalence estimates. There is differential 
misclassification bias in the ascertainment in cross-sectional studies; among 
those with varicose veins, they are reported in excess in the family.
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10.  APPENDICES
Questionnaires in English and in Finnish in 1989 and 1994.
1 
 
QUESTIONNAIRE ON CIRCULATORY PROBLEMS IN THE LOWER EXTREMITIES (1989) 
 
SURNAME_____________________  (FORMER NAME_______________________) 
 
FORENAME________________   1.SOCIAL SECURITY NUMBER      __  __  __  - ____ 
 
2.GENDER       [ ] male   [ ] female 
 
3.PROFESSION_________________                RETIRED [ ]  
  
ADDRESS ________________________________________________________________________  
 
4.Weight _____ kg        Height _____ cm 
 
5.Do any of your closest relatives (parents, grandparents or siblings) have varicose veins? 
[ ] NO  /   [ ] DON’T KNOW 
[ ] YES, who _____________________________________________ 
 
6.Have you ever given birth? 
[ ] NO  /    [ ] YES, how many times? ____ , year of the first birth ____. 
 
7.Have you ever used contraceptive pills? 
[ ] NO  /    [ ] YES, how many years? ____. 
 
DIET AND HABITS: 
 
8.What kind of milk do you drink? 
[ ] whole milk  /    [ ] semi-skimmed milk  /    [ ] skimmed milk  / 
[ ] other, what kind? _________________________________ 
How many glasses (2dl) of milk daily? ______ glasses 
Do you use (e.g. in food and on bread)  [ ] BUTTER /[ ] MARGARINE  /[ ] VEGETABLE OIL 
             [ ] NONE OF THESE 
For how many times each week do you eat meals of meat or sausages? _____ times 
 
How many slices of bread do you eat each day? _____ slices 
 
9.Have you ever smoked for longer than one year? 
 
[ ] NEVER 
[ ] I HAVE STOPPED SMOKING, at what age did you start ____ and stop ____? 
[ ] I NOW SMOKE; -at what age did you start? _____  
                                 -do you smoke     [ ] cigarettes or [ ] cigars  
       [ ] pipe 
    -how much each day? ____ cigarettes/cigars/pipefuls 
 
10.Do you use alcohol? 
 
[ ] NOT AT ALL OR OCCASIONALLY 
[ ] YES, how much per week 
              beer in bottles (1/3 l)  ____ 
              wine in bottles (3/4 l)  ____ or in glasses (12 cl) ____ 
              spirits in bottles (1/2 l)  ____ or in glasses (4 cl)   ____ 
 
11.Do you get any physical exercise when not at work? 
[ ] NOT AT ALL  /    [ ] OCCASIONALLY  /     [ ] EACH WEEK  /    [ ] SEVERAL TIMES A WEEK, 
     which exercise?________________________________________________________ 
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12.Which of the following applies to the posture normally assumed in your main (past or present) occupation? 
 
[ ] SITTING WITH LESS THAN ½  HOUR OF STANDING  IN A DAY 
[ ] MAINLY SITTING, WITH LESS THAN HALF THE WORKING DAY SPENT STANDING 
[ ] STANDING FOR OVER HALF OF THE WORKING DAY 
[ ] OTHER, what posture ________________________________________________________ 
 
IF YOU WORKED ON YOUR FEET, DID YOU WORK IN A STATIC STANDING POSTURE? 
[ ] NO   
[ ] YES, for how many hours daily (on average)? _____ hours 
HOW MANY YEARS? ____ years 
 
PREVIOUS HEALTH: 
 
13.Have you ever suffered conditions requiring medical care? 
 
[ ] NO 
 
[ ] YES, which of these? 
 
-diabetes   [ ] NO    [ ] YES, since _______________ 
-high blood pressure  [ ] NO    [ ] YES, since _______________ 
-cardiac infarct    [ ] NO    [ ] YES, since _______________ 
-angina pectoris  [ ] NO    [ ] YES, since _______________ 
-insufficiency of the heart  [ ] NO    [ ] YES, since _______________ 
-pulmonary diseases  [ ] NO    [ ] YES, which disease ________ 
-superficial thrombosis in lower extremities [ ] NO    [ ] YES, since _______________ 
            in which leg? [ ] right/[ ]left 
-deep venous thrombosis in lower extremities [ ] NO    [ ] YES, since _______________ 
            in which leg? [_] right/[_]left 
-pulmonary embolism  [ ] NO    [ ] YES, since _______________ 
-sciatica or other back problems [ ] NO    [ ] YES, since _______________ 
-renal diseases   [ ] NO    [ ] YES, since _______________ 
-fractures in lower extremities  [ ] NO    [ ] YES, when _______________ 
            in which leg? [ ] right/[ ]left 
                                                          in which part of the leg?__________________________ 
-major contusions with prolonged healing  [ ] NO    [ ] YES, when _______________ 
  in lower extremities          in which leg? [ ] right/[ ]left 
-problems in arterial circulation of the legs [ ] NO    [ ] YES, since _______________ 
            in which leg? [ ] right/[ ]left 
-cerebral circulatory problems  [ ] NO    [ ] YES, since _______________  
-ulceration in leg  [ ] NO    [ ] YES, since _______________ 
            in which leg? [ ] right/[ ]left 
-other chronic or severe disease, which disease? _____________, since _______ 
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14.Have you had a frequent or prolonged experience of the following conditions? (In which leg?) 
 
-sensation of heavy leg(s) in the afternoon  [ ] NO    [ ] YES  ->  [ ]RIGHT/[ ]LEFT 
-pain or prickly sensation in leg(s) during the daytime [ ] NO    [ ] YES  ->  [ ]RIGHT/[ ]LEFT 
-swelling of ankle or leg(s)   [ ] NO    [ ] YES  ->  [ ]RIGHT/[ ]LEFT 
-swelling of thigh(s)   [ ] NO    [ ] YES  ->  [ ]RIGHT/[ ]LEFT 
-considerable leg-pain while standing  [ ] NO    [ ] YES  ->  [ ]RIGHT/[ ]LEFT 
-cold legs    [ ] NO    [ ] YES  ->  [ ]RIGHT/[ ]LEFT 
-numbness in leg(s)   [ ] NO    [ ] YES  ->  [ ]RIGHT/[ ]LEFT 
-cramps in leg(s)   [ ] NO    [ ] YES  ->  [ ]RIGHT/[ ]LEFT 
-permanent change in the color of the skin in ankle or leg [ ] NO    [ ] YES  ->  [ ]RIGHT/[ ]LEFT 
-intermittent claudication (explained)  [ ] NO    [ ] YES  ->  [ ]RIGHT/[ ]LEFT 
-lower-extremity pain while at rest  [ ] NO    [ ] YES  ->  [ ]RIGHT/[ ]LEFT 
-longstanding ulceration or necrosis in foot or leg [ ] NO    [ ] YES  ->  [ ]RIGHT/[ ]LEFT 
-if any of the symptoms have occurred, does it help when you 
 elevate the legs?  [ ] NO    [ ] YES   
 let the legs hang?  [ ] NO    [ ] YES   
-any other symptom?_________________________________________________________________ 
                                       _________________________________________________________________ 
 
 
 
 
 
 
15.Are you on permanent medication? 
 
[ ] NO 
 
[ ] YES, for/medication is 
 
 [ ] diabetes    
 [ ] hypertension  
 [ ] coronary disease 
 [ ] arrhythmia    
 [ ] insufficiency of the heart  
 [ ] pulmonary disease   
 [ ] coagulation  
 [ ] aid to the circulation   
 [ ] pain 
 [ ] constipation 
 [ ] other disease, for which _______________________________________ 
 [ ] cortisone (tablets or injections) 
 [ ] sex hormones 
Names of the drugs:________________________________________________________________ 
 ___________________________________________________________________ 
 ___________________________________________________________________ 
 ___________________________________________________________________ 
 ___________________________________________________________________ 
 ___________________________________________________________________ 
 ___________________________________________________________________ 
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16.Do you now have or have you ever had varicose veins in the lower extremities? 
 
(Varicose veins are clearly visible, dilated, tortuous and possibly prominent subcutaneous veins of the lower 
extremities). 
 
[ ] NO 
[ ] DON’T KNOW 
[] YES 
        Where do the varicose veins exist? [ ] in left thigh  /    [ ] in left leg  /    [ ] in right thigh  /    [ ] in right leg 
        For how many years have they existed?____________ years. 
        When did they appear (for example after trauma/childbirth/other)? 
       
        __________________________________________________________________________________ 
        Do you now have varicose veins?  [ ] NO [ ] YES 
         Are the varicose veins a cosmetic problem? [ ] NO  [ ] YES 
 
        Have you been operated on for varicose veins? 
        [ ] NO  
        [ ] YES in left          ___ times, years______________ 
                             in right       ___  times, years______________ 
       Have you received injections for varicose veins? 
        [ ] NO  
        [ ] YES in left          ___ times, years______________ 
                             in right       ___  times, years______________ 
       Have you been treated for varicose veins with compressive stocking for more than one month? 
        [ ] NO  
        [ ] YES, for_____ months 
        
        Have you been treated for varicose veins with support stocking? 
        [ ] NO  
        [ ] YES, for_____ months 
 
        Have varicose veins reappeared after treatment? 
        [ ] NO   
        [ ] YES,_____ months/______ years after the treatment. 
 
       Do you now need treatment for varicose veins? 
        [ ] NO [ ] YES [_] DON’T KNOW    
 
17.Have you been operated on for any other disease? 
[] NO 
[] YES, which disease and when: 
 
year _______ which operation __________________________ 
 
year _______ which operation __________________________ 
 
year _______ which operation __________________________ 
 
 
                            ################################### 
 Please check that you have answered all questions. A stamped and addressed envelope 
 is included. Mail the questionnaire soon. Thank you! 
                            ################################### 
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QUESTIONNAIRE ON CIRCULATORY PROBLEMS IN THE LOWER EXTREMITIES (1994) 
 
SURNAME_____________________ FORENAME________________ GENDER       [_] male   [_] female 
 
DATE OF BIRTH OR SOCIAL SECURITY NUMBER                   __ __ __ - ____ 
 
Address _____________________________________________________________________  
Profession _______________________________________ 
    Education: 
[_] senior clerical worker   [_] University  
[_] clerical worker   [_] College 
[_] worker    [_] Vocational school  
[_] other _______________   [_] High school  
    [_] Comprehensive school 
    [_] Other _________________ 
Weight _____ kg        and Height _____ cm 
 
DIET AND HABITS: 
 
What kind of milk do you drink? 
[_] WHOLE MILK 
[_] SEMI-SKIMMED MILK 
[_] SKIMMED MILK 
[_] OTHER, WHAT KIND? ______________________ 
How many glasses (2dl) of milk daily? ______ GLASSES 
Do you use (e.g. in food and on bread) 
[_] BUTTER 
[_] MARGARINE 
[_] VEGETABLE OIL 
[_] NONE OF THESE 
 
For how many times each week do you eat meals of meat or sausages? _____ times 
How many slices of bread do you eat each day? _____ slices 
 
Have you ever smoked for longer than one year? 
[_] NEVER 
[_] I HAVE STOPPED SMOKING, at what age did you start ____ and stop ____? 
[_] I NOW SMOKE, at what age did you start? _____  
Do you smoke 
[_] CIGARETTES, [_] CIGARS OR [_] PIPE ? 
How much each day? ____ cigarettes/cigars/pipefuls 
 
Do you use alcohol? 
[_] NOT AT ALL OR OCCASIONALLY 
[_] YES, how much per week 
              beer in bottles (1/3 l)  ____ 
              wine in bottles (3/4 l)  ____ or in glasses (12 cl) ____ 
              spirits in bottles (1/2 l)  ____ or in glasses (4 cl)   ____ 
 
Women: Have you ever given birth? 
[_] NO [_] YES, HOW MANY TIMES? ____ , YEAR OF THE FIRST BIRTH ____. 
 
Women: Have you ever used contraceptive pills? 
[_] NO 
[_] YES, how many years? ____. 
              At what ages did you start using contraceptive pills? __ At what ages did you stop using contraceptive pills? __ 
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Women: Have you ever used hormone replacement therapy? 
[_] NO 
[_] YES, how many years? ____. 
              At what ages did you start using contraceptive pills? __ At what ages did you stop using contraceptive pills? __ 
 
Which of the following applies to the posture normally assumed in your main (past or present) occupation? 
[_] SITTING WITH LESS THAN ½  HOUR OF STANDING  IN A DAY. 
[_] MAINLY SITTING, WITH LESS THAN HALF THE WORKING DAY SPENT STANDING. 
[_] STANDING FOR OVER HALF OF THE WORKING DAY. 
[_] OTHER, what posture ________________________________________________________ 
 
How many years? ____ years 
If you worked on your feet, did you work in a static standing posture? 
[_] NO  [_] YES, for how many hours daily (on average)? _____ hours 
 
PREVIOUS HEALTH: 
 
Have you ever suffered following conditions requiring medical care? 
[_] NO 
[_] YES, which of these? 
 
-diabetes   [_] NO    [_] YES, since _______________ 
-high blood pressure  [_] NO    [_] YES, since _______________ 
-cardiac infarct    [_] NO    [_] YES, since _______________ 
-angina pectoris  [_] NO    [_] YES, since _______________ 
-insufficiency of the heart  [_] NO    [_] YES, since _______________ 
-pulmonary diseases  [_] NO    [_] YES, which disease ________ 
-superficial thrombosis in lower extremities [_] NO    [_] YES, since _______________ 
            in which leg? [_] right/[_]left 
-deep venous thrombosis in lower extremities [_] NO    [_] YES, since _______________ 
            in which leg? [_] right/[_]left 
-pulmonary embolism  [_] NO    [_] YES, since _______________ 
-sciatica or other back problems [_] NO    [_] YES, since _______________ 
-renal diseases   [_] NO    [_] YES, since _______________ 
-problems in arterial circulation of the legs [_] NO    [_] YES, since _______________ 
            in which leg? [_] right/[_]left 
-cerebral circulatory problems  [_] NO    [_] YES, since _______________  
-ulceration in leg  [_] NO    [_] YES, since _______________ 
            in which leg? [_] right/[_]left 
-other chronic or severe disease, which disease? _____________, since _______ 
             
Have you had a frequent or prolonged experience of the following conditions during last month? (In which leg?) 
-sensation of heavy leg(s) in the afternoon  [_] NO    [_] YES  ->  [_]RIGHT/[_]LEFT 
-pain or prickly sensation in leg(s) during the daytime [_] NO    [_] YES  ->  [_]RIGHT/[_]LEFT 
-swelling of ankle or leg(s)   [_] NO    [_] YES  ->  [_]RIGHT/[_]LEFT 
-swelling of thigh(s)   [_] NO    [_] YES  ->  [_]RIGHT/[_]LEFT 
-considerable leg-pain while standing  [_] NO    [_] YES  ->  [_]RIGHT/[_]LEFT 
-cold legs    [_] NO    [_] YES  ->  [_]RIGHT/[_]LEFT 
-numbness in leg(s)   [_] NO    [_] YES  ->  [_]RIGHT/[_]LEFT 
-cramps in leg(s)   [_] NO    [_] YES  ->  [_]RIGHT/[_]LEFT 
-permanent change in the color of the skin in ankle or leg [_] NO    [_] YES  ->  [_]RIGHT/[_]LEFT 
-intermittent claudication (explained)  [_] NO    [_] YES  ->  [_]RIGHT/[_]LEFT 
-lower-extremity pain while at rest  [_] NO    [_] YES  ->  [_]RIGHT/[_]LEFT 
-longstanding ulceration or necrosis in foot or leg [_] NO    [_] YES  ->  [_]RIGHT/[_]LEFT 
 
[_] NONE OF THE ABOVEMENTIONED SYMPTOMS 
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Are you on permanent medication? 
[_] NO 
[_] YES, for/medication is 
 
 [_] diabetes   List the names of the drugs: ____________ 
 [_] hypertension  ___________________________________ 
 [_] coronary disease  ___________________________________ 
 [_] arrhythmia   ___________________________________ 
 [_] insufficiency of the heart  ___________________________________ 
 [_] pulmonary disease  ___________________________________ 
 [_] coagulation   ___________________________________ 
 [_] aid to the circulation  ___________________________________ 
 [_] pain 
 [_] constipation 
 [_] other disease, for which _______________________________________ 
 [_] cortisone (tablets or injections) 
 [_] sex hormones 
 
Do you now have or have you ever had varicose veins in the lower extremities? 
 
(Varicose veins are clearly visible, dilated, tortuous and possibly prominent subcutaneous veins of the lower 
extremities). 
[_] NO 
[_] DON’T KNOW 
[_] YES 
[_] YES, BUT NOT ANYMORE, BECAUSE THEY [_] HAVE BEEN OPERATED ON /[_] HAVE DISAPPEARED  
 
Where do the varicose veins exist? 
[_] in left thigh 
[_] in left leg 
[_] in right thigh 
[_] in right leg 
 
How old were you when varicose veins appeared? __________ years old 
 
Are the varicose veins a cosmetic problem? 
[_] NO  [_] YES 
 
Have you been operated on for varicose veins? 
[_] NO [_] YES, how many times? _____, when? (years) _________________________ 
 
Where have you been operated on for varicose veins? 
[_] in a regional hospital 
[_] in Hatanpää City Hospital 
[_] in Tampere University Hospital 
[_] in another central hospital, which ___________________ 
[_] in a private hospital 
[_] in another hospital, which______________________ 
 
Have you received injections for varicose veins? 
[_] NO [_] YES 
 
Where have you received injections for varicose veins? 
 
[_] in a regional hospital 
[_] in Hatanpää City Hospital 
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[_] in Tampere University Hospital 
[_] in another central hospital, which ___________________ 
[_] in a private hospital 
[_] in another hospital, which______________________ 
 
Have varicose veins reappeared after treatment? 
[_] NO  [_] YES 
 
Do you now need treatment for varicose veins? 
[_] NO [_] DON’T KNOW   [_] YES,  
   What kind of treatment? 
   [_] counseling 
   [_] examination or treatment  
   [_] other, what? ________________ 
 
Are you waiting for treatment for varicose veins? 
[_] NO 
[_] YES,  [_] operation [_] other treatment 
 
Have you been treated for varicose veins with compressive stocking for more than one month? 
[_] NO [_] YES 
 
Have you been treated for varicose veins with support stocking? 
[_] NO [_] YES 
 
Do you closest relatives (parents, grandparents or siblings) have varicose veins? 
[_] NO [_] DON’T KNOW [_] YES, who ______________ 
 
Have you been operated on for any other disease? 
[_] NO 
[_] YES, which disease and when: 
 
year _______ which operation __________________________ 
 
year _______ which operation __________________________ 
 
year _______ which operation __________________________ 
 
 
 ####################################################################### 
 Please check that you have answered all questions. A stamped and addressed envelope 
 is included. Mail the questionnaire soon. Thank you! 
 ####################################################################### 
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